Title: Full Text of HB3705
Official Title: 
Number of Sections: 1
Source: versions - House Amendment 001
Media Type: text/html

================================================================================

Section 1:
Full Text of HB3705 ILGA.GOV HB3705 - 104th General Assembly Rep. Natalie A. ManleyFiled: 3/17/2025   10400HB3705ham001LRB104 11354 BAB 23828 a1AMENDMENT TO HOUSE BILL 37052    AMENDMENT NO. ______. Amend House Bill 3705 by replacing 3everything after the enacting clause with the following: 4    "Section 1. This Act may be referred to as the 5Prescription Drug Affordability Act. 6    Section 5. The State Employees Group Insurance Act of 1971 7is amended by changing Section 6.11 as follows: 8    (5 ILCS 375/6.11)9    Sec. 6.11. Required health benefits; Illinois Insurance 10Code requirements. The program of health benefits shall 11provide the post-mastectomy care benefits required to be 12covered by a policy of accident and health insurance under 13Section 356t of the Illinois Insurance Code. The program of 14health benefits shall provide the coverage required under 15Sections 356g, 356g.5, 356g.5-1, 356m, 356q, 356u, 356u.10,   10400HB3705ham001- 2 -LRB104 11354 BAB 23828 a1356w, 356x, 356z.2, 356z.4, 356z.4a, 356z.5, 356z.6, 356z.8, 2356z.9, 356z.10, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 3356z.17, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 4356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 5356z.51, 356z.53, 356z.54, 356z.55, 356z.56, 356z.57, 356z.59, 6356z.60, 356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 7356z.70, and 356z.71, 356z.74, 356z.76, and 356z.77 of the 8Illinois Insurance Code. The program of health benefits must 9comply with Sections 155.22a, 155.37, 355b, 356z.19, 370c, and 10370c.1 and Article XXXIIB of the Illinois Insurance Code. The 11program of health benefits shall provide the coverage required 12under Section 356m of the Illinois Insurance Code and, for the 13employees of the State Employee Group Insurance Program only, 14the coverage as also provided in Section 6.11B of this Act. The 15Department of Insurance shall enforce the requirements of this 16Section with respect to Sections 370c and 370c.1 and Article 17XXXIIB of the Illinois Insurance Code; all other requirements 18of this Section shall be enforced by the Department of Central 19Management Services.20    Rulemaking authority to implement Public Act 95-1045, if 21any, is conditioned on the rules being adopted in accordance 22with all provisions of the Illinois Administrative Procedure 23Act and all rules and procedures of the Joint Committee on 24Administrative Rules; any purported rule not so adopted, for 25whatever reason, is unauthorized. 26(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22;   10400HB3705ham001- 3 -LRB104 11354 BAB 23828 a1102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 21-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-768, 3eff. 1-1-24; 102-804, eff. 1-1-23; 102-813, eff. 5-13-22; 4102-816, eff. 1-1-23; 102-860, eff. 1-1-23; 102-1093, eff. 51-1-23; 102-1117, eff. 1-13-23; 103-8, eff. 1-1-24; 103-84, 6eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, eff. 1-1-24; 7103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 103-551, eff. 88-11-23; 103-605, eff. 7-1-24; 103-718, eff. 7-19-24; 103-751, 9eff. 8-2-24; 103-870, eff. 1-1-25; 103-914, eff. 1-1-25; 10103-918, eff. 1-1-25; 103-951, eff. 1-1-25; 103-1024, eff. 111-1-25; revised 11-26-24.) 12    Section 10. The School Code is amended by changing Section 1310-22.3f as follows: 14    (105 ILCS 5/10-22.3f)15    Sec. 10-22.3f. Required health benefits. Insurance 16protection and benefits for employees shall provide the 17post-mastectomy care benefits required to be covered by a 18policy of accident and health insurance under Section 356t and 19the coverage required under Sections 356g, 356g.5, 356g.5-1, 20356m, 356q, 356u, 356u.10, 356w, 356x, 356z.4, 356z.4a, 21356z.6, 356z.8, 356z.9, 356z.11, 356z.12, 356z.13, 356z.14, 22356z.15, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 23356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 24356z.51, 356z.53, 356z.54, 356z.56, 356z.57, 356z.59, 356z.60,   10400HB3705ham001- 4 -LRB104 11354 BAB 23828 a1356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 356z.70, and 2356z.71, 356z.74, and 356z.77 of the Illinois Insurance Code. 3Insurance policies shall comply with Section 356z.19 of the 4Illinois Insurance Code. The coverage shall comply with 5Sections 155.22a, 355b, and 370c and Article XXXIIB of the 6Illinois Insurance Code. The Department of Insurance shall 7enforce the requirements of this Section. 8    Rulemaking authority to implement Public Act 95-1045, if 9any, is conditioned on the rules being adopted in accordance 10with all provisions of the Illinois Administrative Procedure 11Act and all rules and procedures of the Joint Committee on 12Administrative Rules; any purported rule not so adopted, for 13whatever reason, is unauthorized. 14(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22; 15102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 161-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-804, 17eff. 1-1-23; 102-813, eff. 5-13-22; 102-816, eff. 1-1-23; 18102-860, eff. 1-1-23; 102-1093, eff. 1-1-23; 102-1117, eff. 191-13-23; 103-84, eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, 20eff. 1-1-24; 103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 21103-551, eff. 8-11-23; 103-605, eff. 7-1-24; 103-718, eff. 227-19-24; 103-751, eff. 8-2-24; 103-914, eff. 1-1-25; 103-918, 23eff. 1-1-25; 103-1024, eff. 1-1-25; revised 11-26-24.) 24    Section 15. The Illinois Insurance Code is amended by 25changing Sections 513b1 and 513b3 and by adding Section   10400HB3705ham001- 5 -LRB104 11354 BAB 23828 a1513b1.1 as follows: 2    (215 ILCS 5/513b1)3    Sec. 513b1. Pharmacy benefit manager contracts.4    (a) As used in this Section: 5    "340B drug discount program" means the program established 6under Section 340B of the federal Public Health Service Act, 742 U.S.C. 256b. 8    "340B entity" means a covered entity as defined in 42 9U.S.C. 256b(a)(4) authorized to participate in the 340B drug 10discount program. 11    "340B pharmacy" means any pharmacy used to dispense 340B 12drugs for a covered entity, whether entity-owned or external.13    "Affiliate" means a person or entity that directly or 14indirectly through one or more intermediaries controls or is 15controlled by, or is under common control with, the person or 16entity specified.17    "Biological product" has the meaning ascribed to that term 18in Section 19.5 of the Pharmacy Practice Act.19    "Brand name drug" means a drug that has been approved 20under 42 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 21marketed, sold, or distributed under a proprietary, 22trademark-protected name.23    "Complex or chronic medical condition" means a physical, 24behavioral, or developmental condition that has no known cure, 25is progressive, or can be debilitating or fatal if unmanaged   10400HB3705ham001- 6 -LRB104 11354 BAB 23828 a1or untreated.2    "Covered individual" means a member, participant, 3enrollee, contract holder, policyholder, or beneficiary of a 4health benefit plan who is provided a drug benefit by the 5health benefit plan.6    "Critical access pharmacy" means a critical access care 7pharmacy as defined in Section 5-5.12b of the Illinois Public 8Aid Code.9    "Drugs" has the meaning ascribed to that term in Section 3 10of the Pharmacy Practice Act and includes biological products.11    "Generic drug" means a drug that has been approved under 1242 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 13marketed, sold, or distributed directly or indirectly to the 14retail class of trade with labeling, packaging (other than 15repackaging as the listed drug in blister packs, unit doses, 16or similar packaging for use in institutions), product code, 17labeler code, trade name, or trademark that differs from that 18of the brand name drug.19    "Health benefit plan" means a policy, contract, 20certificate, or agreement entered into, offered, or issued by 21an insurer to provide, deliver, arrange for, pay for, or 22reimburse any of the costs of physical, mental, or behavioral 23health care services. Notwithstanding Sections 122-1 through 24122-4 of this Code, "health benefit plan" includes self-funded 25employee welfare benefit plans.26    "Maximum allowable cost" means the maximum amount that a   10400HB3705ham001- 7 -LRB104 11354 BAB 23828 a1pharmacy benefit manager will reimburse a pharmacy for the 2cost of a drug. 3    "Maximum allowable cost list" means a list of drugs for 4which a maximum allowable cost has been established by a 5pharmacy benefit manager. 6    "Pharmacy benefit manager" means a person, business, or 7entity, including a wholly or partially owned or controlled 8subsidiary of a pharmacy benefit manager, that provides claims 9processing services or other prescription drug or device 10services, or both, for health benefit plans.11    "Pharmacy services" means the provision of any services 12listed within the definition of "practice of pharmacy" under 13subsection (d) of Section 3 of the Pharmacy Practice Act.14    "Rare medical condition" means a physical, behavioral, or 15developmental condition that affects fewer than 200,000 16individuals in the United States or approximately 1 in 1,500 17individuals worldwide.18    "Rebate aggregator" means a person or entity, including 19group purchasing organizations, that negotiate rebates or 20other fees with drug manufacturers on behalf or for the 21benefit of a pharmacy benefit manager or its client and may 22also be involved in contracts that entitle the rebate 23aggregator or its client to receive rebates or other fees from 24drug manufacturers based on drug utilization or 25administration. 26    "Retail price" means the price an individual without   10400HB3705ham001- 8 -LRB104 11354 BAB 23828 a1prescription drug coverage would pay at a retail pharmacy, not 2including a pharmacist dispensing fee. 3    "Specialty drug" means a drug that:4        (1) is prescribed for a person with a complex or 5    chronic medical condition or a rare medical condition;6        (2) has limited or exclusive distribution; and7        (3) requires both:8            (A) specialized product handling by the dispensing 9        pharmacy or administration by the dispensing pharmacy; 10        and11            (B) specialized clinical care, including frequent 12        dosing adjustments, intensive clinical monitoring, or 13        expanded services for patients, including intensive 14        patient counseling, education, or ongoing clinical 15        support beyond traditional dispensing activities, such 16        as individualized disease and therapy management to 17        support improved health outcomes.18    "Spread pricing" means the model of drug pricing in which 19the pharmacy benefit manager charges a health benefit plan a 20contracted price for drugs, and the contracted price for the 21drugs differs from the amount the pharmacy benefit manager 22directly or indirectly pays the pharmacist or pharmacy for 23pharmacist services or drug and dispensing fees.24    "Steer" includes, but is not limited to:25        (1) requiring a covered individual to use only a 26    pharmacy, including a mail-order or specialty pharmacy, in   10400HB3705ham001- 9 -LRB104 11354 BAB 23828 a1    which the pharmacy benefit manager or its affiliate 2    maintains an ownership interest or control;3        (2) offering or implementing a plan design that 4    encourages a covered individual to use a pharmacy in which 5    the pharmacy benefit manager or an affiliate maintains an 6    ownership interest or control, if such plan design 7    increases costs for the covered individual. This includes 8    a plan design that requires a covered individual to pay 9    higher costs or an increased share of costs for a drug or 10    drug-related service if the covered individual uses a 11    pharmacy that is not owned or controlled by the pharmacy 12    benefit manager.13        (3) reimbursing a pharmacy or pharmacist for a 14    pharmaceutical product and pharmacist service in an amount 15    less than the amount that the pharmacy benefit manager 16    reimburses itself or an affiliate, including affiliated 17    manufacturers or joint ventures for providing the same 18    product or services. 19    "Third-party payer" means any entity that pays for 20prescription drugs on behalf of a patient other than a health 21care provider or sponsor of a plan subject to regulation under 22Medicare Part D, 42 U.S.C. 1395w-101 et seq.23    (a-5) In this Article, references to an "insurer" or 24"health insurer" shall include commercial private health 25insurance issuers, managed care organizations, managed care 26community networks, and any other third-party payer that   10400HB3705ham001- 10 -LRB104 11354 BAB 23828 a1contracts with pharmacy benefit managers or with the 2Department of Healthcare and Family Services to provide 3benefits or services under the Medicaid program or to 4otherwise engage in the administration or payment of pharmacy 5benefits. However, the terms do not refer to the plan sponsor 6of a self-funded, single-employer employee welfare benefit 7plan subject to 29 U.S.C. 1144.8    (b) A contract between a health insurer and a pharmacy 9benefit manager must require that the pharmacy benefit 10manager: 11        (1) Update maximum allowable cost pricing information 12    at least every 7 calendar days. 13        (2) Maintain a process that will, in a timely manner, 14    eliminate drugs from maximum allowable cost lists or 15    modify drug prices to remain consistent with changes in 16    pricing data used in formulating maximum allowable cost 17    prices and product availability. 18        (3) Provide access to its maximum allowable cost list 19    to each pharmacy or pharmacy services administrative 20    organization subject to the maximum allowable cost list. 21    Access may include a real-time pharmacy website portal to 22    be able to view the maximum allowable cost list. As used in 23    this Section, "pharmacy services administrative 24    organization" means an entity operating within the State 25    that contracts with independent pharmacies to conduct 26    business on their behalf with third-party payers. A   10400HB3705ham001- 11 -LRB104 11354 BAB 23828 a1    pharmacy services administrative organization may provide 2    administrative services to pharmacies and negotiate and 3    enter into contracts with third-party payers or pharmacy 4    benefit managers on behalf of pharmacies. 5        (4) Provide a process by which a contracted pharmacy 6    can appeal the provider's reimbursement for a drug subject 7    to maximum allowable cost pricing. The appeals process 8    must, at a minimum, include the following: 9            (A) A requirement that a contracted pharmacy has 10        14 calendar days after the applicable fill date to 11        appeal a maximum allowable cost if the reimbursement 12        for the drug is less than the net amount that the 13        network provider paid to the supplier of the drug. 14            (B) A requirement that a pharmacy benefit manager 15        must respond to a challenge within 14 calendar days of 16        the contracted pharmacy making the claim for which the 17        appeal has been submitted.18            (C) A telephone number and e-mail address or 19        website to network providers, at which the provider 20        can contact the pharmacy benefit manager to process 21        and submit an appeal.22            (D) A requirement that, if an appeal is denied, 23        the pharmacy benefit manager must provide the reason 24        for the denial and the name and the national drug code 25        number from national or regional wholesalers.26            (E) A requirement that, if an appeal is sustained,   10400HB3705ham001- 12 -LRB104 11354 BAB 23828 a1        the pharmacy benefit manager must make an adjustment 2        in the drug price effective the date the challenge is 3        resolved and make the adjustment applicable to all 4        similarly situated network pharmacy providers, as 5        determined by the managed care organization or 6        pharmacy benefit manager. 7        (5) Allow a plan sponsor or insurer whose coverage is 8    administered by the contracting with a pharmacy benefit 9    manager an annual right to audit compliance with the terms 10    of the contract by the pharmacy benefit manager, 11    including, but not limited to, full disclosure of any and 12    all rebate amounts secured, whether product specific or 13    generalized rebates, that were provided to the pharmacy 14    benefit manager by a pharmaceutical manufacturer. The cost 15    of the audit shall be borne exclusively by the pharmacy 16    benefit manager. 17        (6) Allow a plan sponsor or insurer whose coverage is 18    administered by the contracting with a pharmacy benefit 19    manager to request that the pharmacy benefit manager 20    disclose the actual amounts paid by the pharmacy benefit 21    manager to the pharmacy.22        (7) Provide notice to the plan sponsor or the insurer 23    party contracting with the pharmacy benefit manager of any 24    consideration that the pharmacy benefit manager receives 25    from the manufacturer for dispense as written 26    prescriptions once a generic or biologically similar   10400HB3705ham001- 13 -LRB104 11354 BAB 23828 a1    product becomes available. 2    (c) In order to place a particular prescription drug on a 3maximum allowable cost list, the pharmacy benefit manager 4must, at a minimum, ensure that: 5        (1) if the drug is a generically equivalent drug, it 6    is listed as therapeutically equivalent and 7    pharmaceutically equivalent "A" or "B" rated in the United 8    States Food and Drug Administration's most recent version 9    of the "Orange Book" or have an NR or NA rating by 10    Medi-Span, Gold Standard, or a similar rating by a 11    nationally recognized reference; 12        (2) the drug is available for purchase by each 13    pharmacy in the State from national or regional 14    wholesalers operating in Illinois; and 15        (3) the drug is not obsolete. 16    (d) A pharmacy benefit manager is prohibited from limiting 17a pharmacist's ability to disclose whether the cost-sharing 18obligation exceeds the retail price for a covered prescription 19drug, and the availability of a more affordable alternative 20drug, if one is available in accordance with Section 42 of the 21Pharmacy Practice Act. 22    (e) A health insurer or pharmacy benefit manager shall not 23require a covered individual an insured to make a payment for a 24prescription drug at the point of sale in an amount that 25exceeds the lesser of: 26        (1) the applicable cost-sharing amount; or  10400HB3705ham001- 14 -LRB104 11354 BAB 23828 a1        (2) the retail price of the drug in the absence of 2    prescription drug coverage;3        (3) the discounted price available through a no cost 4    drug program or drug manufacturer voucher provided by or 5    for the covered individual at the point of sale; or6        (4) the discounted price available through a 7    discounted health care services plan provided by or for 8    the covered individual at the point of sale. 9    (f) Unless required by law, a contract between a pharmacy 10benefit manager or third-party payer and a 340B entity or 340B 11pharmacy shall not contain any provision that: 12        (1) distinguishes between drugs purchased through the 13    340B drug discount program and other drugs when 14    determining reimbursement or reimbursement methodologies, 15    or contains otherwise less favorable payment terms or 16    reimbursement methodologies for 340B entities or 340B 17    pharmacies when compared to similarly situated non-340B 18    entities; 19        (2) imposes any fee, chargeback, or rate adjustment 20    that is not similarly imposed on similarly situated 21    pharmacies that are not 340B entities or 340B pharmacies; 22        (3) imposes any fee, chargeback, or rate adjustment 23    that exceeds the fee, chargeback, or rate adjustment that 24    is not similarly imposed on similarly situated pharmacies 25    that are not 340B entities or 340B pharmacies; 26        (4) prevents or interferes with an individual's choice   10400HB3705ham001- 15 -LRB104 11354 BAB 23828 a1    to receive a covered prescription drug from a 340B entity 2    or 340B pharmacy through any legally permissible means, 3    except that nothing in this paragraph shall prohibit the 4    establishment of differing copayments or other 5    cost-sharing amounts within the health benefit plan for 6    covered individuals persons who acquire covered 7    prescription drugs from a nonpreferred or nonparticipating 8    provider; 9        (5) excludes a 340B entity or 340B pharmacy from a 10    pharmacy network on any basis that includes consideration 11    of whether the 340B entity or 340B pharmacy participates 12    in the 340B drug discount program; 13        (6) prevents a 340B entity or 340B pharmacy from using 14    a drug purchased under the 340B drug discount program; or 15        (7) any other provision that discriminates against a 16    340B entity or 340B pharmacy by treating the 340B entity 17    or 340B pharmacy differently than non-340B entities or 18    non-340B pharmacies for any reason relating to the 19    entity's participation in the 340B drug discount program. 20    As used in this subsection, "pharmacy benefit manager" and 21"third-party payer" do not include pharmacy benefit managers 22and third-party payers acting on behalf of a Medicaid program.23    (f-5) A pharmacy benefit manager or an affiliate acting on 24its behalf must reimburse pharmacies no less than 90% of the 25amount the pharmacy benefit manager, or its affiliate, charges 26the insurer or plan sponsor for the drug, item, or service.   10400HB3705ham001- 16 -LRB104 11354 BAB 23828 a1Spread pricing percentages by drug, insurer or plan sponsor, 2and pharmacy must be disclosed to the Department in an annual 3spread pricing filing. Any amount not paid to the pharmacies 4must be excluded from the 90% threshold.5    (f-10) A pharmacy benefit manager or an affiliate acting 6on its behalf shall not steer a covered individual.7    (f-15) A pharmacy benefit manager or rebate aggregator 8must remit no less than 90% of any amounts paid by a 9pharmaceutical manufacturer, wholesaler, or other distributor 10of a drug, including, but not limited to, rebates, group 11purchasing fees, and other fees, to the health benefit plan 12sponsor, covered individual, or employer. Records of rebates 13and fees remitted from the pharmacy benefit manager or rebate 14aggregator must be disclosed to the Department annually in a 15format to be specified by the Department.16    (f-20) A pharmacy benefit manager must not reimburse a 17critical access pharmacy for a drug or pharmacy service in an 18amount less than the national average drug acquisition cost 19for the drug or pharmacy service at the time the drug is 20administered or dispensed, plus the current Medicaid critical 21access pharmacy dispensing fee. If the national average drug 22acquisition cost is not available at the time a drug is 23administered or dispensed, a pharmacy benefit manager must not 24reimburse a critical access pharmacy for any drug at a rate 25that is less than the amount established by the Department of 26Healthcare and Family Services for the drug or service under   10400HB3705ham001- 17 -LRB104 11354 BAB 23828 a1the Medicaid program, as set forth in the applicable 2administrative rule, plus the current Medicaid critical access 3pharmacy dispensing fee.4    (f-25) A pharmacy benefit manager or an affiliate acting 5on its behalf is prohibited from limiting a covered 6individual's access to drugs from a pharmacy or pharmacist 7enrolled with the health benefit plan under the terms offered 8to all pharmacies in the plan coverage area, including by 9designating the covered drug as a specialty drug contrary to 10the definition in this Section.11    (f-30) The contract between the pharmacy benefit manager 12and the insurer or health benefit plan sponsor must allow and 13provide for the pharmacy benefit manager's compliance with an 14audit at least once per calendar year of the rebate and fee 15records remitted from a pharmacy benefit manager or its 16affiliated party to a health benefit plan. This audit may be 17incorporated into the audit under paragraph (5) of subsection 18(b) of this Section. Contracts with rebate aggregators, 19pharmacy services administrative organizations, pharmacies, or 20drug manufacturers must be available for audit by health 21benefit plan sponsors, insurers, or their designees at least 22once per plan year. Audits shall be performed by an auditor 23selected by the health benefit plan sponsor, insurer, or its 24designee. Health benefit plan sponsors and insurers shall give 25the pharmacy benefit manager a complete copy of the audit and 26the pharmacy benefit manager shall provide a complete copy of   10400HB3705ham001- 18 -LRB104 11354 BAB 23828 a1those findings to the Department within 60 days of initial 2receipt. Rebate contracts with rebate aggregators, pharmacy 3services administrative organizations, pharmacies, or drug 4manufacturers shall be available for audit by health benefit 5plan sponsor, insurer, or designee. Nothing in this Section 6shall limit the Department's ability to access the books and 7records and any and all copies thereof of pharmacy benefit 8managers, their affiliates, or affiliated rebate aggregators. 9    (g) A violation of this Section by a pharmacy benefit 10manager constitutes an unfair or deceptive act or practice in 11the business of insurance under Section 424. 12    (h) A provision that violates subsection (f) in a contract 13between a pharmacy benefit manager or a third-party payer and 14a 340B entity that is entered into, amended, or renewed after 15July 1, 2022 shall be void and unenforceable. This subsection 16and subsection (f) do not apply to a contract between a 340B 17entity and the plan sponsor of a self-funded, single-employer 18employee welfare benefit plan subject to 29 U.S.C. 1144. 19    (i)(1) A pharmacy benefit manager may not retaliate 20against a pharmacist or pharmacy for disclosing information in 21a court, in an administrative hearing, before a legislative 22commission or committee, or in any other proceeding, if the 23pharmacist or pharmacy has reasonable cause to believe that 24the disclosed information is evidence of a violation of a 25State or federal law, rule, or regulation.26    (2) A pharmacy benefit manager may not retaliate against a   10400HB3705ham001- 19 -LRB104 11354 BAB 23828 a1pharmacist or pharmacy for disclosing information to a 2government or law enforcement agency, if the pharmacist or 3pharmacy has reasonable cause to believe that the disclosed 4information is evidence of a violation of a State or federal 5law, rule, or regulation.6    (3) A pharmacist or pharmacy shall make commercially 7reasonable efforts to limit the disclosure of confidential and 8proprietary information.9    (4) Retaliatory actions against a pharmacy or pharmacist 10include cancellation of, restriction of, or refusal to renew 11or offer a contract to a pharmacy solely because the pharmacy 12or pharmacist has:13        (A) made disclosures of information that the 14    pharmacist or pharmacy has reasonable cause to believe is 15    evidence of a violation of a State or federal law, rule, or 16    regulation;17        (B) filed complaints with the plan or pharmacy benefit 18    manager; or19        (C) filed complaints against the plan or pharmacy 20    benefit manager with the Department.21    (j) This Section applies to contracts entered into or 22renewed on or after July 1, 2022 and, unless provided 23otherwise in this Section or in the Illinois Public Aid Code, 24applies to pharmacy benefit managers that are contracted with 25a Medicaid managed care entity on or after January 1, 2026. 26    (k) This Section applies to any health benefit group or   10400HB3705ham001- 20 -LRB104 11354 BAB 23828 a1individual policy of accident and health insurance or managed 2care plan that provides coverage for prescription drugs and 3that is amended, delivered, issued, or renewed on or after 4January 1, 2026 July 1, 2020. 5    (l) A pharmacy benefit manager is responsible for 6compliance with all State requirements applicable to pharmacy 7benefit managers even if an action or responsibility of a 8pharmacy benefit manager is delegated to or completed by a 9third party with an affiliation or a direct or indirect 10contractual relationship. The changes made to this Section by 11this amendatory Act of the 104th General Assembly shall apply 12with respect to any health benefit plan that provides coverage 13for drugs that is amended, delivered, issued, or renewed on or 14after January 1, 2026. 15(Source: P.A. 102-778, eff. 7-1-22; 103-154, eff. 6-30-23; 16103-453, eff. 8-4-23.) 17    (215 ILCS 5/513b1.1 new)18    Sec. 513b1.1. Pharmacy benefit manager reporting 19requirements.20    (a) A pharmacy benefit manager that provides services for 21a health benefit plan must submit an annual report no later 22than September 1, to the Department, each health benefit plan 23sponsor, and each insurer that includes the following:24        (1) data on the health benefit plan including:25            (A) a list of drugs including corresponding   10400HB3705ham001- 21 -LRB104 11354 BAB 23828 a1        information on therapeutic class, brand name, generic 2        name, or specialty drug name;3            (B) number of covered individuals;4            (C) number of drug-related claims;5            (D) dosage units;6            (E) dispensing channel used;7            (F) wholesale acquisition cost; and8            (G) total out-of-pocket spending by deidentified 9        covered individual;10        (2) amount received by the health benefit plan in 11    rebates, fees, or discounts related to drug utilization or 12    spending;13        (3) total gross spending on drugs by the health 14    benefit plan;15        (4) total net spending, gross spending less 16    administrative portion of the medical loss ratio, spread 17    pricing, on drugs by the health benefit plan;18        (5) the amount paid by the health benefit plan to the 19    pharmacy benefit manager for reimbursement cost of a drug 20    per transaction;21        (6) the amount a pharmacy benefit manager paid for 22    pharmacists' services rendered related to the health 23    benefit plan per transaction, including, but not limited 24    to, any dispensing fee;25        (7) the specific rebate amount received by the 26    pharmacy benefit manager per transaction, the amount of   10400HB3705ham001- 22 -LRB104 11354 BAB 23828 a1    the rebates passed through to the health benefit plan per 2    transaction, and the amount of the rebates passed on to 3    covered individuals at the point of sale that reduced the 4    covered individuals' applicable deductible, copayment, 5    coinsurance, or other cost-sharing amount per transaction;6        (8) any information collected from drug manufacturers 7    pertaining to copayment assistance;8        (9) any compensation paid to brokers, consultants, 9    advisors, or any other individual or firm for referrals, 10    consideration, or retention by the health benefit plan;11        (10) explanation of benefit design parameters 12    encouraging or requiring covered individuals to use 13    affiliated pharmacies, percentage of drugs charged by 14    these pharmacies, and a list of drugs dispensed by 15    affiliated pharmacies with their associated costs; and16        (11) a complete copy of each unredacted contract the 17    pharmacy benefit manager has with the health benefit plan 18    sponsor or insurer.19    (b) Annual reports pursuant to subsection (a):20        (1) must be written in plain language to ensure ease 21    of reading and accessibility.22        (2) must only contain summary health information to 23    ensure plan, coverage, or covered individual information 24    remains private and confidential.25        (3) upon request by a covered individual, must be 26    available in summary format and provide aggregated   10400HB3705ham001- 23 -LRB104 11354 BAB 23828 a1    information to help covered individuals understand their 2    health benefit plan's drug coverage.3        (4) must be filed with the Department no later than 4    September 1 of each year via the Systems for Electronic 5    Rates & Forms Filing (SERFF). The filing shall include the 6    summary version of the report described in paragraph (3) 7    of this subsection, which shall be marked for public 8    access.9    (c) A pharmacy benefit manager may petition the Department 10for a filing submission extension. The Director may grant or 11deny the extension within 5 business days.12    (d) Failure by a pharmacy benefit manager to submit all 13required elements in an annual report to the Department may 14result in a fine levied by the Director not to exceed $10,000 15per day, per offense. Funds derived from fines levied shall be 16deposited into the Insurance Producer Administration Fund. 17Fine information shall be posted on the Department's website.18    (e) A pharmacy benefit manager found in violation of 19subsection (a) or paragraph (4) of subsection (b) may request 20a hearing from the Director within 10 days of receipt of the 21Director's order, or, if the violation is found in a market 22conduct examination, as provided in Section 132 of this Code.23    (f) Except for the summary version, the annual reports 24submitted by pharmacy benefit managers shall be considered 25confidential and privileged for all purposes, including for 26purposes of the Freedom of Information Act, shall not be   10400HB3705ham001- 24 -LRB104 11354 BAB 23828 a1subject to subpoena from any private party, and shall not be 2admissible as evidence in a civil action.3    (g) A copy of an adverse decision against a pharmacy 4benefit manager for failing to submit an annual report to the 5Department must be posted to the Department's website.6    (h) Nothing in this Section shall be construed as 7permitting a pharmacy benefit manager to avoid or otherwise 8fail to comply with the reporting requirements set forth in 9Section 5-36 of the Illinois Public Aid Code. 10    (215 ILCS 5/513b3)11    Sec. 513b3. Examination. 12    (a) The Director, or his or her designee, may examine a 13registered pharmacy benefit manager related to all of its 14lines of business, including government programs, under the 15Director's jurisdiction in accordance with Sections 132-132.7. 16If the Director or the examiners find that the pharmacy 17benefit manager has violated this Article or any other 18insurance-related or health benefits-related laws, rules, or 19regulations under the Director's jurisdiction because of the 20manner in which the pharmacy benefit manager has conducted 21business on behalf of a health insurer or plan sponsor, then, 22unless the health insurer or plan sponsor is included in the 23examination and has been afforded the same opportunity to 24request or participate in a hearing on the examination report, 25the examination report shall not allege a violation by the   10400HB3705ham001- 25 -LRB104 11354 BAB 23828 a1health insurer or plan sponsor and the Director's order based 2on the report shall not impose any requirements, prohibitions, 3or penalties on the health insurer or plan sponsor. Nothing in 4this Section shall prevent the Director from using any 5information obtained during the examination of an 6administrator to examine, investigate, or take other 7appropriate regulatory or legal action with respect to a 8health insurer or plan sponsor.9    (b) The examination requirement for the pharmacy benefit 10manager to provide convenient and free access to all books and 11records under Sections 132 and 132.4 of this Code includes, at 12the Director's discretion, unredacted copies furnished 13electronically to the Director's market conduct surveillance 14personnel or examiners. Access must include information 15related to third-party entities affiliated or contracted with 16the pharmacy benefit manager, including, but not limited, to, 17rebate aggregators and pharmacy services administrative 18organizations. 19(Source: P.A. 103-897, eff. 1-1-25.) 20    Section 20. The Illinois Public Aid Code is amended by 21changing Sections 5-5.12b and 5-36 as follows: 22    (305 ILCS 5/5-5.12b)23    Sec. 5-5.12b. Critical access care pharmacy program.24    (a) As used in this Section:   10400HB3705ham001- 26 -LRB104 11354 BAB 23828 a1    "Critical access care pharmacy" means an Illinois-based 2brick and mortar pharmacy that is located in Illinois that is 3owned by a person or entity with an ownership or control 4interest in a county with fewer than 50,000 residents and that 5owns fewer than 10 pharmacies, and is either located in a 6county with fewer than 50,000 residents or in a county with 750,000 or more residents and in an area within Illinois that is 8designated as a Medically Underserved Area by the Health 9Resources and Services Administration, an agency of the U.S. 10Department of Health and Human Services, or at the discretion 11of the Department of Healthcare and Family Services, as set 12forth in administrative rule. 13    "Critical access care pharmacy program payment" means the 14number of individual prescriptions a critical access care 15pharmacy fills during that quarter multiplied by the lesser of 16the individual payment amount or the dispensing reimbursement 17rate made by the Department under the medical assistance 18program as of April 1, 2018. 19    "Individual payment amount" means the dividend of 1/4 of 20the annual amount appropriated for the critical access care 21pharmacy program by the number of prescriptions filled by all 22critical access care pharmacies reimbursed by Medicaid managed 23care organizations that quarter. 24    (b) Subject to appropriations, the Department shall 25establish a critical access care pharmacy program to ensure 26the sustainability of critical access pharmacies throughout   10400HB3705ham001- 27 -LRB104 11354 BAB 23828 a1the State of Illinois. 2    (c) The critical access care pharmacy program shall not 3exceed $10,000,000 annually and individual payment amounts per 4prescription shall not exceed the dispensing rate that the 5Department would have reimbursed under the Medical Assistance 6Program as of April 1, 2018. 7    (d) Quarterly, the Department shall determine the number 8of prescriptions filled by critical access care pharmacies 9reimbursed by Medicaid managed care organizations utilizing 10encounter data available to the Department. The Department 11shall determine the individual payment amount per prescription 12by dividing 1/4 of the annual amount appropriated for the 13critical access care pharmacy program by the number of 14prescriptions filled by all critical access care pharmacies 15reimbursed by Medicaid managed care organizations that 16quarter. If the individual payment amount per prescription as 17calculated using quarterly prescription amounts exceeds the 18reimbursement rate under the medical assistance program as of 19April 1, 2018, then the individual payment amount per 20prescription shall be the dispensing reimbursement rate under 21the medical assistance program as of April 1, 2018. 22    (e) Quarterly, the Department shall distribute to critical 23access care pharmacies a critical access care pharmacy program 24payment. The first payment shall be calculated utilizing the 25encounter data from the last quarter of State fiscal year 262018.  10400HB3705ham001- 28 -LRB104 11354 BAB 23828 a1    (f) The Department may adopt rules permitting an 2Illinois-based brick and mortar pharmacy that owns fewer than 310 pharmacies to receive critical access care pharmacy program 4payments in the same manner as a critical access care 5pharmacy, regardless of whether the pharmacy is located in a 6county with a population of less than 50,000. 7(Source: P.A. 100-587, eff. 6-4-18.) 8    (305 ILCS 5/5-36)9    Sec. 5-36. Pharmacy benefits. 10    (a)(1) The Department may enter into a contract with a 11third party on a fee-for-service reimbursement model for the 12purpose of administering pharmacy benefits as provided in this 13Section for members not enrolled in a Medicaid managed care 14organization; however, these services shall be approved by the 15Department. The Department shall ensure coordination of care 16between the third-party administrator and managed care 17organizations as a consideration in any contracts established 18in accordance with this Section. Any managed care techniques, 19principles, or administration of benefits utilized in 20accordance with this subsection shall comply with State law. 21    (2) The following shall apply to contracts between 22entities contracting relating to the Department's third-party 23administrators and pharmacies: 24        (A) the Department shall approve any contract between 25    a third-party administrator and a pharmacy;  10400HB3705ham001- 29 -LRB104 11354 BAB 23828 a1        (B) the Department's third-party administrator shall 2    not change the terms of a contract between a third-party 3    administrator and a pharmacy without written approval by 4    the Department; and5        (C) the Department's third-party administrator shall 6    not create, modify, implement, or indirectly establish any 7    fee on a pharmacy, pharmacist, or a recipient of medical 8    assistance without written approval by the Department. 9    (b) The provisions of this Section shall not apply to 10outpatient pharmacy services provided by a health care 11facility registered as a covered entity pursuant to 42 U.S.C. 12256b or any pharmacy owned by or contracted with the covered 13entity. A Medicaid managed care organization shall, either 14directly or through a pharmacy benefit manager, administer and 15reimburse outpatient pharmacy claims submitted by a health 16care facility registered as a covered entity pursuant to 42 17U.S.C. 256b, its owned pharmacies, and contracted pharmacies 18in accordance with the contractual agreements the Medicaid 19managed care organization or its pharmacy benefit manager has 20with such facilities and pharmacies and in accordance with 21subsection (h-5). 22    (b-5) Any pharmacy benefit manager that contracts with a 23Medicaid managed care organization to administer and reimburse 24pharmacy claims as provided in this Section must be registered 25with the Director of Insurance in accordance with Section 26513b2 of the Illinois Insurance Code. A pharmacy benefit   10400HB3705ham001- 30 -LRB104 11354 BAB 23828 a1manager must comply with all provisions of Article XXXIIB of 2the Illinois Insurance Code to the extent that they do not 3prevent the application of any provision of this Article or 4applicable federal law. Nothing in this Section shall be 5construed to limit the authority of the Illinois Department or 6the Inspector General to administer or enforce any provisions 7of this Section or any other Section in the Illinois Public Aid 8Code related to pharmacy benefit managers or Medicaid managed 9care entity. 10    (c) On at least an annual basis, the Director of the 11Department of Healthcare and Family Services shall submit a 12report beginning no later than one year after January 1, 2020 13(the effective date of Public Act 101-452) that provides an 14update on any contract, contract issues, formulary, dispensing 15fees, and maximum allowable cost concerns regarding a 16third-party administrator and managed care. The requirement 17for reporting to the General Assembly shall be satisfied by 18filing copies of the report with the Speaker, the Minority 19Leader, and the Clerk of the House of Representatives and with 20the President, the Minority Leader, and the Secretary of the 21Senate. The Department shall take care that no proprietary 22information is included in the report required under this 23Section. 24    (d) (Blank). A pharmacy benefit manager shall notify the 25Department in writing of any activity, policy, or practice of 26the pharmacy benefit manager that directly or indirectly   10400HB3705ham001- 31 -LRB104 11354 BAB 23828 a1presents a conflict of interest that interferes with the 2discharge of the pharmacy benefit manager's duty to a managed 3care organization to exercise its contractual duties. 4"Conflict of interest" shall be defined by rule by the 5Department.6    (e) A pharmacy benefit manager shall, upon request, 7disclose to the Department the following information: 8        (1) whether the pharmacy benefit manager has a 9    contract, agreement, or other arrangement with a 10    pharmaceutical manufacturer to exclusively dispense or 11    provide a drug to a managed care organization's enrollees, 12    and the aggregate amounts of consideration of economic 13    benefits collected or received pursuant to that 14    arrangement; 15        (2) the percentage of claims payments made by the 16    pharmacy benefit manager to pharmacies owned, managed, or 17    controlled by the pharmacy benefit manager or any of the 18    pharmacy benefit manager's management companies, parent 19    companies, subsidiary companies, or jointly held 20    companies; 21        (3) the aggregate amount of the fees or assessments 22    imposed on, or collected from, pharmacy providers; 23        (4) the average annualized percentage of revenue 24    collected by the pharmacy benefit manager as a result of 25    each contract it has executed with a managed care 26    organization contracted by the Department to provide   10400HB3705ham001- 32 -LRB104 11354 BAB 23828 a1    medical assistance benefits which is not paid by the 2    pharmacy benefit manager to pharmacy providers and 3    pharmaceutical manufacturers or labelers or in order to 4    perform administrative functions pursuant to its contracts 5    with managed care organizations; 6        (5) the total number of prescriptions dispensed under 7    each contract the pharmacy benefit manager has with a 8    managed care organization (MCO) contracted by the 9    Department to provide medical assistance benefits;10        (6) the aggregate wholesale acquisition cost for drugs 11    that were dispensed to enrollees in each MCO with which 12    the pharmacy benefit manager has a contract by any 13    pharmacy owned, managed, or controlled by the pharmacy 14    benefit manager or any of the pharmacy benefit manager's 15    management companies, parent companies, subsidiary 16    companies, or jointly-held companies; 17        (7) the aggregate amount of administrative fees that 18    the pharmacy benefit manager received from all 19    pharmaceutical manufacturers for prescriptions dispensed 20    to MCO enrollees; 21        (8) for each MCO with which the pharmacy benefit 22    manager has a contract, the aggregate amount of payments 23    received by the pharmacy benefit manager from the MCO; 24        (9) for each MCO with which the pharmacy benefit 25    manager has a contract, the aggregate amount of 26    reimbursements the pharmacy benefit manager paid to   10400HB3705ham001- 33 -LRB104 11354 BAB 23828 a1    contracting pharmacies; and 2        (10) any other information considered necessary by the 3    Department. 4    (f) The information disclosed under subsection (e) shall 5include all retail, mail order, specialty, and compounded 6prescription products. All information made available to the 7Department under subsection (e) is confidential and not 8subject to disclosure under the Freedom of Information Act. 9All information made available to the Department under 10subsection (e) shall not be reported or distributed in any way 11that compromises its competitive, proprietary, or financial 12value. The information shall only be used by the Department to 13assess the contract, agreement, or other arrangements made 14between a pharmacy benefit manager and a pharmacy provider, 15pharmaceutical manufacturer or labeler, managed care 16organization, or other entity, as applicable. 17    (g) A pharmacy benefit manager shall disclose directly in 18writing to a pharmacy provider or pharmacy services 19administrative organization contracting with the pharmacy 20benefit manager of any material change to a contract provision 21that affects the terms of the reimbursement, the process for 22verifying benefits and eligibility, dispute resolution, 23procedures for verifying drugs included on the formulary, and 24contract termination at least 30 days prior to the date of the 25change to the provision. The terms of this subsection shall be 26deemed met if the pharmacy benefit manager posts the   10400HB3705ham001- 34 -LRB104 11354 BAB 23828 a1information on a website, viewable by the public. A pharmacy 2service administration organization shall notify all contract 3pharmacies of any material change, as described in this 4subsection, within 2 days of notification. As used in this 5Section, "pharmacy services administrative organization" means 6an entity operating within the State that contracts with 7independent pharmacies to conduct business on their behalf 8with third-party payers. A pharmacy services administrative 9organization may provide administrative services to pharmacies 10and negotiate and enter into contracts with third-party payers 11or pharmacy benefit managers on behalf of pharmacies. 12    (h) A pharmacy benefit manager shall not include the 13following in a contract with a pharmacy provider: 14        (1) a provision prohibiting the provider from 15    informing a patient of a less costly alternative to a 16    prescribed medication; or 17        (2) a provision that prohibits the provider from 18    dispensing a particular amount of a prescribed medication, 19    if the pharmacy benefit manager allows that amount to be 20    dispensed through a pharmacy owned or controlled by the 21    pharmacy benefit manager, unless the prescription drug is 22    subject to restricted distribution by the United States 23    Food and Drug Administration or requires special handling, 24    provider coordination, or patient education that cannot be 25    provided by a retail pharmacy. 26    (h-5) Unless required by law, a Medicaid managed care   10400HB3705ham001- 35 -LRB104 11354 BAB 23828 a1organization or pharmacy benefit manager administering or 2managing benefits on behalf of a Medicaid managed care 3organization shall not refuse to contract with a 340B entity 4or 340B pharmacy for refusing to accept less favorable payment 5terms or reimbursement methodologies when compared to 6similarly situated non-340B entities and shall not include in 7a contract with a 340B entity or 340B pharmacy a provision 8that: 9        (1) imposes any fee, chargeback, or rate adjustment 10    that is not similarly imposed on similarly situated 11    pharmacies that are not 340B entities or 340B pharmacies; 12        (2) imposes any fee, chargeback, or rate adjustment 13    that exceeds the fee, chargeback, or rate adjustment that 14    is not similarly imposed on similarly situated pharmacies 15    that are not 340B entities or 340B pharmacies; 16        (3) prevents or interferes with an individual's choice 17    to receive a prescription drug from a 340B entity or 340B 18    pharmacy through any legally permissible means; 19        (4) excludes a 340B entity or 340B pharmacy from a 20    pharmacy network on the basis of whether the 340B entity 21    or 340B pharmacy participates in the 340B drug discount 22    program; 23        (5) prevents a 340B entity or 340B pharmacy from using 24    a drug purchased under the 340B drug discount program so 25    long as the drug recipient is a patient of the 340B entity; 26    nothing in this Section exempts a 340B pharmacy from   10400HB3705ham001- 36 -LRB104 11354 BAB 23828 a1    following the Department's preferred drug list or from any 2    prior approval requirements of the Department or the 3    Medicaid managed care organization that are imposed on the 4    drug for all pharmacies; or 5        (6) any other provision that discriminates against a 6    340B entity or 340B pharmacy by treating a 340B entity or 7    340B pharmacy differently than non-340B entities or 8    non-340B pharmacies for any reason relating to the 9    entity's participation in the 340B drug discount program. 10    A provision that violates this subsection in any contract 11between a Medicaid managed care organization or its pharmacy 12benefit manager and a 340B entity entered into, amended, or 13renewed after July 1, 2022 shall be void and unenforceable. 14    In this subsection (h-5):15    "340B entity" means a covered entity as defined in 42 16U.S.C. 256b(a)(4) authorized to participate in the 340B drug 17discount program.18    "340B pharmacy" means any pharmacy used to dispense 340B 19drugs for a covered entity, whether entity-owned or external. 20    (i) Nothing in this Section shall be construed to prohibit 21a pharmacy benefit manager from requiring the same 22reimbursement and terms and conditions for a pharmacy provider 23as for a pharmacy owned, controlled, or otherwise associated 24with the pharmacy benefit manager. 25    (j) A pharmacy benefit manager shall establish and 26implement a process for the resolution of disputes arising out   10400HB3705ham001- 37 -LRB104 11354 BAB 23828 a1of this Section, which shall be approved by the Department. 2    (k) The Department shall adopt rules establishing 3reasonable dispensing fees for fee-for-service payments in 4accordance with guidance or guidelines from the federal 5Centers for Medicare and Medicaid Services.6(Source: P.A. 102-558, eff. 8-20-21; 102-778, eff. 7-1-22; 7103-593, eff. 6-7-24.) 8    Section 25. The Juvenile Court Act of 1987 is amended by 9changing Section 5-515 as follows: 10    (705 ILCS 405/5-515)11    Sec. 5-515. Medical, and dental, and pharmaceutical 12treatment and care. 13    (a) At all times during temporary custody, detention or 14shelter care, the court may authorize a physician, a hospital 15or any other appropriate health care provider to provide 16medical, dental or surgical procedures or pharmaceuticals if 17those procedures or pharmaceuticals are necessary to safeguard 18the minor's life or health. If the minor is covered under an 19existing medical or dental plan, the county shall be 20reimbursed for the expenses incurred for such services as if 21the minor were not held in temporary custody, detention, or 22shelter care.23    (b) If a provider of temporary custody, detention, or 24shelter care has a contract with a pharmacy benefit manager or   10400HB3705ham001- 38 -LRB104 11354 BAB 23828 a1a contract with an insurance company, health maintenance 2organization, limited health service organization, 3administrative services organization, or any other managed 4care organization or health insurance issuer where a pharmacy 5benefit manager administers the provider's coverage of, 6payment for, or formulary design for drugs necessary to 7safeguard the minor's life or health, the contract with the 8pharmacy benefit manager and the pharmacy benefit manager's 9activities shall be subject to Article XXXIIB of the Illinois 10Insurance Code and the authority of the Director of Insurance 11to enforce such provisions. The provider shall have all the 12rights of a plan sponsor under those provisions. 13(Source: P.A. 90-590, eff. 1-1-99.) 14    Section 30. The Unified Code of Corrections is amended by 15changing Section 3-2-2 as follows: 16    (730 ILCS 5/3-2-2)  (from Ch. 38, par. 1003-2-2)17    Sec. 3-2-2. Powers and duties of the Department. 18    (1) In addition to the powers, duties, and 19responsibilities which are otherwise provided by law, the 20Department shall have the following powers:21        (a) To accept persons committed to it by the courts of 22    this State for care, custody, treatment, and 23    rehabilitation, and to accept federal prisoners and 24    noncitizens over whom the Office of the Federal Detention   10400HB3705ham001- 39 -LRB104 11354 BAB 23828 a1    Trustee is authorized to exercise the federal detention 2    function for limited purposes and periods of time.3        (b) To develop and maintain reception and evaluation 4    units for purposes of analyzing the custody and 5    rehabilitation needs of persons committed to it and to 6    assign such persons to institutions and programs under its 7    control or transfer them to other appropriate agencies. In 8    consultation with the Department of Alcoholism and 9    Substance Abuse (now the Department of Human Services), 10    the Department of Corrections shall develop a master plan 11    for the screening and evaluation of persons committed to 12    its custody who have alcohol or drug abuse problems, and 13    for making appropriate treatment available to such 14    persons; the Department shall report to the General 15    Assembly on such plan not later than April 1, 1987. The 16    maintenance and implementation of such plan shall be 17    contingent upon the availability of funds.18        (b-1) To create and implement, on January 1, 2002, a 19    pilot program to establish the effectiveness of 20    pupillometer technology (the measurement of the pupil's 21    reaction to light) as an alternative to a urine test for 22    purposes of screening and evaluating persons committed to 23    its custody who have alcohol or drug problems. The pilot 24    program shall require the pupillometer technology to be 25    used in at least one Department of Corrections facility. 26    The Director may expand the pilot program to include an   10400HB3705ham001- 40 -LRB104 11354 BAB 23828 a1    additional facility or facilities as he or she deems 2    appropriate. A minimum of 4,000 tests shall be included in 3    the pilot program. The Department must report to the 4    General Assembly on the effectiveness of the program by 5    January 1, 2003.6        (b-5) To develop, in consultation with the Illinois 7    State Police, a program for tracking and evaluating each 8    inmate from commitment through release for recording his 9    or her gang affiliations, activities, or ranks.10        (c) To maintain and administer all State correctional 11    institutions and facilities under its control and to 12    establish new ones as needed. Pursuant to its power to 13    establish new institutions and facilities, the Department 14    may, with the written approval of the Governor, authorize 15    the Department of Central Management Services to enter 16    into an agreement of the type described in subsection (d) 17    of Section 405-300 of the Department of Central Management 18    Services Law. The Department shall designate those 19    institutions which shall constitute the State Penitentiary 20    System. The Department of Juvenile Justice shall maintain 21    and administer all State youth centers pursuant to 22    subsection (d) of Section 3-2.5-20. 23        Pursuant to its power to establish new institutions 24    and facilities, the Department may authorize the 25    Department of Central Management Services to accept bids 26    from counties and municipalities for the construction,   10400HB3705ham001- 41 -LRB104 11354 BAB 23828 a1    remodeling, or conversion of a structure to be leased to 2    the Department of Corrections for the purposes of its 3    serving as a correctional institution or facility. Such 4    construction, remodeling, or conversion may be financed 5    with revenue bonds issued pursuant to the Industrial 6    Building Revenue Bond Act by the municipality or county. 7    The lease specified in a bid shall be for a term of not 8    less than the time needed to retire any revenue bonds used 9    to finance the project, but not to exceed 40 years. The 10    lease may grant to the State the option to purchase the 11    structure outright.12        Upon receipt of the bids, the Department may certify 13    one or more of the bids and shall submit any such bids to 14    the General Assembly for approval. Upon approval of a bid 15    by a constitutional majority of both houses of the General 16    Assembly, pursuant to joint resolution, the Department of 17    Central Management Services may enter into an agreement 18    with the county or municipality pursuant to such bid.19        (c-5) To build and maintain regional juvenile 20    detention centers and to charge a per diem to the counties 21    as established by the Department to defray the costs of 22    housing each minor in a center. In this subsection (c-5), 23    "juvenile detention center" means a facility to house 24    minors during pendency of trial who have been transferred 25    from proceedings under the Juvenile Court Act of 1987 to 26    prosecutions under the criminal laws of this State in   10400HB3705ham001- 42 -LRB104 11354 BAB 23828 a1    accordance with Section 5-805 of the Juvenile Court Act of 2    1987, whether the transfer was by operation of law or 3    permissive under that Section. The Department shall 4    designate the counties to be served by each regional 5    juvenile detention center.6        (d) To develop and maintain programs of control, 7    rehabilitation, and employment of committed persons within 8    its institutions.9        (d-5) To provide a pre-release job preparation program 10    for inmates at Illinois adult correctional centers. 11        (d-10) To provide educational and visitation 12    opportunities to committed persons within its institutions 13    through temporary access to content-controlled tablets 14    that may be provided as a privilege to committed persons 15    to induce or reward compliance. 16        (e) To establish a system of supervision and guidance 17    of committed persons in the community.18        (f) To establish in cooperation with the Department of 19    Transportation to supply a sufficient number of prisoners 20    for use by the Department of Transportation to clean up 21    the trash and garbage along State, county, township, or 22    municipal highways as designated by the Department of 23    Transportation. The Department of Corrections, at the 24    request of the Department of Transportation, shall furnish 25    such prisoners at least annually for a period to be agreed 26    upon between the Director of Corrections and the Secretary   10400HB3705ham001- 43 -LRB104 11354 BAB 23828 a1    of Transportation. The prisoners used on this program 2    shall be selected by the Director of Corrections on 3    whatever basis he deems proper in consideration of their 4    term, behavior and earned eligibility to participate in 5    such program - where they will be outside of the prison 6    facility but still in the custody of the Department of 7    Corrections. Prisoners convicted of first degree murder, 8    or a Class X felony, or armed violence, or aggravated 9    kidnapping, or criminal sexual assault, aggravated 10    criminal sexual abuse or a subsequent conviction for 11    criminal sexual abuse, or forcible detention, or arson, or 12    a prisoner adjudged a Habitual Criminal shall not be 13    eligible for selection to participate in such program. The 14    prisoners shall remain as prisoners in the custody of the 15    Department of Corrections and such Department shall 16    furnish whatever security is necessary. The Department of 17    Transportation shall furnish trucks and equipment for the 18    highway cleanup program and personnel to supervise and 19    direct the program. Neither the Department of Corrections 20    nor the Department of Transportation shall replace any 21    regular employee with a prisoner.22        (g) To maintain records of persons committed to it and 23    to establish programs of research, statistics, and 24    planning.25        (h) To investigate the grievances of any person 26    committed to the Department and to inquire into any   10400HB3705ham001- 44 -LRB104 11354 BAB 23828 a1    alleged misconduct by employees or committed persons; and 2    for these purposes it may issue subpoenas and compel the 3    attendance of witnesses and the production of writings and 4    papers, and may examine under oath any witnesses who may 5    appear before it; to also investigate alleged violations 6    of a parolee's or releasee's conditions of parole or 7    release; and for this purpose it may issue subpoenas and 8    compel the attendance of witnesses and the production of 9    documents only if there is reason to believe that such 10    procedures would provide evidence that such violations 11    have occurred.12        If any person fails to obey a subpoena issued under 13    this subsection, the Director may apply to any circuit 14    court to secure compliance with the subpoena. The failure 15    to comply with the order of the court issued in response 16    thereto shall be punishable as contempt of court.17        (i) To appoint and remove the chief administrative 18    officers, and administer programs of training and 19    development of personnel of the Department. Personnel 20    assigned by the Department to be responsible for the 21    custody and control of committed persons or to investigate 22    the alleged misconduct of committed persons or employees 23    or alleged violations of a parolee's or releasee's 24    conditions of parole shall be conservators of the peace 25    for those purposes, and shall have the full power of peace 26    officers outside of the facilities of the Department in   10400HB3705ham001- 45 -LRB104 11354 BAB 23828 a1    the protection, arrest, retaking, and reconfining of 2    committed persons or where the exercise of such power is 3    necessary to the investigation of such misconduct or 4    violations. This subsection shall not apply to persons 5    committed to the Department of Juvenile Justice under the 6    Juvenile Court Act of 1987 on aftercare release.7        (j) To cooperate with other departments and agencies 8    and with local communities for the development of 9    standards and programs for better correctional services in 10    this State.11        (k) To administer all moneys and properties of the 12    Department.13        (l) To report annually to the Governor on the 14    committed persons, institutions, and programs of the 15    Department.16        (l-5) (Blank).17        (m) To make all rules and regulations and exercise all 18    powers and duties vested by law in the Department.19        (n) To establish rules and regulations for 20    administering a system of sentence credits, established in 21    accordance with Section 3-6-3, subject to review by the 22    Prisoner Review Board.23        (o) To administer the distribution of funds from the 24    State Treasury to reimburse counties where State penal 25    institutions are located for the payment of assistant 26    state's attorneys' salaries under Section 4-2001 of the   10400HB3705ham001- 46 -LRB104 11354 BAB 23828 a1    Counties Code.2        (p) To exchange information with the Department of 3    Human Services and the Department of Healthcare and Family 4    Services for the purpose of verifying living arrangements 5    and for other purposes directly connected with the 6    administration of this Code and the Illinois Public Aid 7    Code.8        (q) To establish a diversion program.9        The program shall provide a structured environment for 10    selected technical parole or mandatory supervised release 11    violators and committed persons who have violated the 12    rules governing their conduct while in work release. This 13    program shall not apply to those persons who have 14    committed a new offense while serving on parole or 15    mandatory supervised release or while committed to work 16    release.17        Elements of the program shall include, but shall not 18    be limited to, the following:19            (1) The staff of a diversion facility shall 20        provide supervision in accordance with required 21        objectives set by the facility.22            (2) Participants shall be required to maintain 23        employment.24            (3) Each participant shall pay for room and board 25        at the facility on a sliding-scale basis according to 26        the participant's income.  10400HB3705ham001- 47 -LRB104 11354 BAB 23828 a1            (4) Each participant shall:2                (A) provide restitution to victims in 3            accordance with any court order;4                (B) provide financial support to his 5            dependents; and6                (C) make appropriate payments toward any other 7            court-ordered obligations.8            (5) Each participant shall complete community 9        service in addition to employment.10            (6) Participants shall take part in such 11        counseling, educational, and other programs as the 12        Department may deem appropriate.13            (7) Participants shall submit to drug and alcohol 14        screening.15            (8) The Department shall promulgate rules 16        governing the administration of the program.17        (r) To enter into intergovernmental cooperation 18    agreements under which persons in the custody of the 19    Department may participate in a county impact 20    incarceration program established under Section 3-6038 or 21    3-15003.5 of the Counties Code.22        (r-5) (Blank).23        (r-10) To systematically and routinely identify with 24    respect to each streetgang active within the correctional 25    system: (1) each active gang; (2) every existing 26    inter-gang affiliation or alliance; and (3) the current   10400HB3705ham001- 48 -LRB104 11354 BAB 23828 a1    leaders in each gang. The Department shall promptly 2    segregate leaders from inmates who belong to their gangs 3    and allied gangs. "Segregate" means no physical contact 4    and, to the extent possible under the conditions and space 5    available at the correctional facility, prohibition of 6    visual and sound communication. For the purposes of this 7    paragraph (r-10), "leaders" means persons who:8            (i) are members of a criminal streetgang;9            (ii) with respect to other individuals within the 10        streetgang, occupy a position of organizer, 11        supervisor, or other position of management or 12        leadership; and13            (iii) are actively and personally engaged in 14        directing, ordering, authorizing, or requesting 15        commission of criminal acts by others, which are 16        punishable as a felony, in furtherance of streetgang 17        related activity both within and outside of the 18        Department of Corrections.19    "Streetgang", "gang", and "streetgang related" have the 20    meanings ascribed to them in Section 10 of the Illinois 21    Streetgang Terrorism Omnibus Prevention Act.22        (s) To operate a super-maximum security institution, 23    in order to manage and supervise inmates who are 24    disruptive or dangerous and provide for the safety and 25    security of the staff and the other inmates.26        (t) To monitor any unprivileged conversation or any   10400HB3705ham001- 49 -LRB104 11354 BAB 23828 a1    unprivileged communication, whether in person or by mail, 2    telephone, or other means, between an inmate who, before 3    commitment to the Department, was a member of an organized 4    gang and any other person without the need to show cause or 5    satisfy any other requirement of law before beginning the 6    monitoring, except as constitutionally required. The 7    monitoring may be by video, voice, or other method of 8    recording or by any other means. As used in this 9    subdivision (1)(t), "organized gang" has the meaning 10    ascribed to it in Section 10 of the Illinois Streetgang 11    Terrorism Omnibus Prevention Act.12        As used in this subdivision (1)(t), "unprivileged 13    conversation" or "unprivileged communication" means a 14    conversation or communication that is not protected by any 15    privilege recognized by law or by decision, rule, or order 16    of the Illinois Supreme Court.17        (u) To establish a Women's and Children's Pre-release 18    Community Supervision Program for the purpose of providing 19    housing and services to eligible female inmates, as 20    determined by the Department, and their newborn and young 21    children.22        (u-5) To issue an order, whenever a person committed 23    to the Department absconds or absents himself or herself, 24    without authority to do so, from any facility or program 25    to which he or she is assigned. The order shall be 26    certified by the Director, the Supervisor of the   10400HB3705ham001- 50 -LRB104 11354 BAB 23828 a1    Apprehension Unit, or any person duly designated by the 2    Director, with the seal of the Department affixed. The 3    order shall be directed to all sheriffs, coroners, and 4    police officers, or to any particular person named in the 5    order. Any order issued pursuant to this subdivision 6    (1)(u-5) shall be sufficient warrant for the officer or 7    person named in the order to arrest and deliver the 8    committed person to the proper correctional officials and 9    shall be executed the same as criminal process. 10        (u-6) To appoint a point of contact person who shall 11    receive suggestions, complaints, or other requests to the 12    Department from visitors to Department institutions or 13    facilities and from other members of the public.14        (v) To do all other acts necessary to carry out the 15    provisions of this Chapter.16    (2) The Department of Corrections shall by January 1, 171998, consider building and operating a correctional facility 18within 100 miles of a county of over 2,000,000 inhabitants, 19especially a facility designed to house juvenile participants 20in the impact incarceration program.21    (3) When the Department lets bids for contracts for 22medical services to be provided to persons committed to 23Department facilities by a health maintenance organization, 24medical service corporation, or other health care provider, 25the bid may only be let to a health care provider that has 26obtained an irrevocable letter of credit or performance bond   10400HB3705ham001- 51 -LRB104 11354 BAB 23828 a1issued by a company whose bonds have an investment grade or 2higher rating by a bond rating organization.3    (3.5) If the Department has a contract with a pharmacy 4benefit manager or a contract with an insurance company, 5health maintenance organization, limited health service 6organization, administrative services organization, or any 7other managed care entity or health insurance issuer where a 8pharmacy benefit manager administers the provider's coverage 9of, payment for, or formulary design for drugs necessary to 10safeguard the minor's life or health, the contract with the 11pharmacy benefit manager and the pharmacy benefit manager's 12activities shall be subject to Article XXXIIB of the Illinois 13Insurance Code and the authority of the Director of Insurance 14to enforce such provisions. The provider shall have all the 15rights of a plan sponsor under those provisions. 16    (4) When the Department lets bids for contracts for food 17or commissary services to be provided to Department 18facilities, the bid may only be let to a food or commissary 19services provider that has obtained an irrevocable letter of 20credit or performance bond issued by a company whose bonds 21have an investment grade or higher rating by a bond rating 22organization.23    (5) On and after the date 6 months after August 16, 2013 24(the effective date of Public Act 98-488), as provided in the 25Executive Order 1 (2012) Implementation Act, all of the 26powers, duties, rights, and responsibilities related to State   10400HB3705ham001- 52 -LRB104 11354 BAB 23828 a1healthcare purchasing under this Code that were transferred 2from the Department of Corrections to the Department of 3Healthcare and Family Services by Executive Order 3 (2005) are 4transferred back to the Department of Corrections; however, 5powers, duties, rights, and responsibilities related to State 6healthcare purchasing under this Code that were exercised by 7the Department of Corrections before the effective date of 8Executive Order 3 (2005) but that pertain to individuals 9resident in facilities operated by the Department of Juvenile 10Justice are transferred to the Department of Juvenile Justice. 11    (6) The Department of Corrections shall provide lactation 12or nursing mothers rooms for personnel of the Department. The 13rooms shall be provided in each facility of the Department 14that employs nursing mothers. Each individual lactation room 15must: 16        (i) contain doors that lock; 17        (ii) have an "Occupied" sign for each door; 18        (iii) contain electrical outlets for plugging in 19    breast pumps; 20        (iv) have sufficient lighting and ventilation; 21        (v) contain comfortable chairs; 22        (vi) contain a countertop or table for all necessary 23    supplies for lactation; 24        (vii) contain a wastebasket and chemical cleaners to 25    wash one's hands and to clean the surfaces of the 26    countertop or table;   10400HB3705ham001- 53 -LRB104 11354 BAB 23828 a1        (viii) have a functional sink; 2        (ix) have a minimum of one refrigerator for storage of 3    the breast milk; and 4        (x) receive routine daily maintenance. 5(Source: P.A. 102-350, eff. 8-13-21; 102-535, eff. 1-1-22; 6102-538, eff. 8-20-21; 102-813, eff. 5-13-22; 102-1030, eff. 75-27-22; 103-834, eff. 1-1-25.) 8    Section 35. The County Jail Act is amended by changing 9Section 17 as follows: 10    (730 ILCS 125/17)  (from Ch. 75, par. 117)11    Sec. 17. Bedding, clothing, fuel, and medical aid; 12reimbursement for medical expenses. The Warden of the jail 13shall furnish necessary bedding, clothing, fuel, and medical 14services for all committed persons under his charge, and keep 15an accurate account of the same. When services that result in 16qualified medical expenses are required by any person held in 17custody, the county, private hospital, physician or any public 18agency which provides such services shall be entitled to 19obtain reimbursement from the county for the cost of such 20services. The county board of a county may adopt an ordinance 21or resolution providing for reimbursement for the cost of 22those services at the Department of Healthcare and Family 23Services' rates for medical assistance. To the extent that 24such person is reasonably able to pay for such care, including   10400HB3705ham001- 54 -LRB104 11354 BAB 23828 a1reimbursement from any insurance program or from other medical 2benefit programs available to such person, he or she shall 3reimburse the county or arresting authority. If such person 4has already been determined eligible for medical assistance 5under the Illinois Public Aid Code at the time the person is 6detained, the cost of such services, to the extent such cost 7exceeds $500, shall be reimbursed by the Department of 8Healthcare and Family Services under that Code. A 9reimbursement under any public or private program authorized 10by this Section shall be paid to the county or arresting 11authority to the same extent as would have been obtained had 12the services been rendered in a non-custodial environment.13    The sheriff or his or her designee may cause an 14application for medical assistance under the Illinois Public 15Aid Code to be completed for an arrestee who is a hospital 16inpatient. If such arrestee is determined eligible, he or she 17shall receive medical assistance under the Code for hospital 18inpatient services only. An arresting authority shall be 19responsible for any qualified medical expenses relating to the 20arrestee until such time as the arrestee is placed in the 21custody of the sheriff. However, the arresting authority shall 22not be so responsible if the arrest was made pursuant to a 23request by the sheriff. When medical expenses are required by 24any person held in custody, the county shall be entitled to 25obtain reimbursement from the County Jail Medical Costs Fund 26to the extent moneys are available from the Fund. To the extent   10400HB3705ham001- 55 -LRB104 11354 BAB 23828 a1that the person is reasonably able to pay for that care, 2including reimbursement from any insurance program or from 3other medical benefit programs available to the person, he or 4she shall reimburse the county.5    For the purposes of this Section, "arresting authority" 6means a unit of local government, other than a county, which 7employs peace officers and whose peace officers have made the 8arrest of a person. For the purposes of this Section, 9"qualified medical expenses" include medical and hospital 10services but do not include (i) expenses incurred for medical 11care or treatment provided to a person on account of a 12self-inflicted injury incurred prior to or in the course of an 13arrest, (ii) expenses incurred for medical care or treatment 14provided to a person on account of a health condition of that 15person which existed prior to the time of his or her arrest, or 16(iii) expenses for hospital inpatient services for arrestees 17enrolled for medical assistance under the Illinois Public Aid 18Code.19    If a jail or a unit of local government operating the jail 20has a contract with a pharmacy benefit manager or a contract 21with an insurance company, health maintenance organization, 22limited health service organization, administrative services 23organization, or any other managed care organization or health 24insurance issuer where a pharmacy benefit manager administers 25coverage of, payment for, or formulary design for drugs 26necessary to safeguard the life or health of any person in   10400HB3705ham001- 56 -LRB104 11354 BAB 23828 a1custody, that contract and the pharmacy benefit manager's 2activities shall be subject to Article XXXIIB of the Illinois 3Insurance Code and the authority of the Director of Insurance 4to enforce such provisions. The jail or unit of local 5government shall have all the rights of a plan sponsor under 6those provisions. 7(Source: P.A. 103-745, eff. 1-1-25.) 8    Section 99. Effective date. This Act takes effect on 9January 1, 2026, except that this Section and the changes to 10Section 513b3 of the Illinois Insurance Code take effect upon 11becoming law.".


================================================================================

Raw Text:
Full Text of HB3705 ILGA.GOV HB3705 - 104th General Assembly Rep. Natalie A. ManleyFiled: 3/17/2025   10400HB3705ham001LRB104 11354 BAB 23828 a1AMENDMENT TO HOUSE BILL 37052    AMENDMENT NO. ______. Amend House Bill 3705 by replacing 3everything after the enacting clause with the following: 4    "Section 1. This Act may be referred to as the 5Prescription Drug Affordability Act. 6    Section 5. The State Employees Group Insurance Act of 1971 7is amended by changing Section 6.11 as follows: 8    (5 ILCS 375/6.11)9    Sec. 6.11. Required health benefits; Illinois Insurance 10Code requirements. The program of health benefits shall 11provide the post-mastectomy care benefits required to be 12covered by a policy of accident and health insurance under 13Section 356t of the Illinois Insurance Code. The program of 14health benefits shall provide the coverage required under 15Sections 356g, 356g.5, 356g.5-1, 356m, 356q, 356u, 356u.10,   10400HB3705ham001- 2 -LRB104 11354 BAB 23828 a1356w, 356x, 356z.2, 356z.4, 356z.4a, 356z.5, 356z.6, 356z.8, 2356z.9, 356z.10, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 3356z.17, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 4356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 5356z.51, 356z.53, 356z.54, 356z.55, 356z.56, 356z.57, 356z.59, 6356z.60, 356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 7356z.70, and 356z.71, 356z.74, 356z.76, and 356z.77 of the 8Illinois Insurance Code. The program of health benefits must 9comply with Sections 155.22a, 155.37, 355b, 356z.19, 370c, and 10370c.1 and Article XXXIIB of the Illinois Insurance Code. The 11program of health benefits shall provide the coverage required 12under Section 356m of the Illinois Insurance Code and, for the 13employees of the State Employee Group Insurance Program only, 14the coverage as also provided in Section 6.11B of this Act. The 15Department of Insurance shall enforce the requirements of this 16Section with respect to Sections 370c and 370c.1 and Article 17XXXIIB of the Illinois Insurance Code; all other requirements 18of this Section shall be enforced by the Department of Central 19Management Services.20    Rulemaking authority to implement Public Act 95-1045, if 21any, is conditioned on the rules being adopted in accordance 22with all provisions of the Illinois Administrative Procedure 23Act and all rules and procedures of the Joint Committee on 24Administrative Rules; any purported rule not so adopted, for 25whatever reason, is unauthorized. 26(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22;   10400HB3705ham001- 3 -LRB104 11354 BAB 23828 a1102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 21-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-768, 3eff. 1-1-24; 102-804, eff. 1-1-23; 102-813, eff. 5-13-22; 4102-816, eff. 1-1-23; 102-860, eff. 1-1-23; 102-1093, eff. 51-1-23; 102-1117, eff. 1-13-23; 103-8, eff. 1-1-24; 103-84, 6eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, eff. 1-1-24; 7103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 103-551, eff. 88-11-23; 103-605, eff. 7-1-24; 103-718, eff. 7-19-24; 103-751, 9eff. 8-2-24; 103-870, eff. 1-1-25; 103-914, eff. 1-1-25; 10103-918, eff. 1-1-25; 103-951, eff. 1-1-25; 103-1024, eff. 111-1-25; revised 11-26-24.) 12    Section 10. The School Code is amended by changing Section 1310-22.3f as follows: 14    (105 ILCS 5/10-22.3f)15    Sec. 10-22.3f. Required health benefits. Insurance 16protection and benefits for employees shall provide the 17post-mastectomy care benefits required to be covered by a 18policy of accident and health insurance under Section 356t and 19the coverage required under Sections 356g, 356g.5, 356g.5-1, 20356m, 356q, 356u, 356u.10, 356w, 356x, 356z.4, 356z.4a, 21356z.6, 356z.8, 356z.9, 356z.11, 356z.12, 356z.13, 356z.14, 22356z.15, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 23356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 24356z.51, 356z.53, 356z.54, 356z.56, 356z.57, 356z.59, 356z.60,   10400HB3705ham001- 4 -LRB104 11354 BAB 23828 a1356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 356z.70, and 2356z.71, 356z.74, and 356z.77 of the Illinois Insurance Code. 3Insurance policies shall comply with Section 356z.19 of the 4Illinois Insurance Code. The coverage shall comply with 5Sections 155.22a, 355b, and 370c and Article XXXIIB of the 6Illinois Insurance Code. The Department of Insurance shall 7enforce the requirements of this Section. 8    Rulemaking authority to implement Public Act 95-1045, if 9any, is conditioned on the rules being adopted in accordance 10with all provisions of the Illinois Administrative Procedure 11Act and all rules and procedures of the Joint Committee on 12Administrative Rules; any purported rule not so adopted, for 13whatever reason, is unauthorized. 14(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22; 15102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 161-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-804, 17eff. 1-1-23; 102-813, eff. 5-13-22; 102-816, eff. 1-1-23; 18102-860, eff. 1-1-23; 102-1093, eff. 1-1-23; 102-1117, eff. 191-13-23; 103-84, eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, 20eff. 1-1-24; 103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 21103-551, eff. 8-11-23; 103-605, eff. 7-1-24; 103-718, eff. 227-19-24; 103-751, eff. 8-2-24; 103-914, eff. 1-1-25; 103-918, 23eff. 1-1-25; 103-1024, eff. 1-1-25; revised 11-26-24.) 24    Section 15. The Illinois Insurance Code is amended by 25changing Sections 513b1 and 513b3 and by adding Section   10400HB3705ham001- 5 -LRB104 11354 BAB 23828 a1513b1.1 as follows: 2    (215 ILCS 5/513b1)3    Sec. 513b1. Pharmacy benefit manager contracts.4    (a) As used in this Section: 5    "340B drug discount program" means the program established 6under Section 340B of the federal Public Health Service Act, 742 U.S.C. 256b. 8    "340B entity" means a covered entity as defined in 42 9U.S.C. 256b(a)(4) authorized to participate in the 340B drug 10discount program. 11    "340B pharmacy" means any pharmacy used to dispense 340B 12drugs for a covered entity, whether entity-owned or external.13    "Affiliate" means a person or entity that directly or 14indirectly through one or more intermediaries controls or is 15controlled by, or is under common control with, the person or 16entity specified.17    "Biological product" has the meaning ascribed to that term 18in Section 19.5 of the Pharmacy Practice Act.19    "Brand name drug" means a drug that has been approved 20under 42 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 21marketed, sold, or distributed under a proprietary, 22trademark-protected name.23    "Complex or chronic medical condition" means a physical, 24behavioral, or developmental condition that has no known cure, 25is progressive, or can be debilitating or fatal if unmanaged   10400HB3705ham001- 6 -LRB104 11354 BAB 23828 a1or untreated.2    "Covered individual" means a member, participant, 3enrollee, contract holder, policyholder, or beneficiary of a 4health benefit plan who is provided a drug benefit by the 5health benefit plan.6    "Critical access pharmacy" means a critical access care 7pharmacy as defined in Section 5-5.12b of the Illinois Public 8Aid Code.9    "Drugs" has the meaning ascribed to that term in Section 3 10of the Pharmacy Practice Act and includes biological products.11    "Generic drug" means a drug that has been approved under 1242 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 13marketed, sold, or distributed directly or indirectly to the 14retail class of trade with labeling, packaging (other than 15repackaging as the listed drug in blister packs, unit doses, 16or similar packaging for use in institutions), product code, 17labeler code, trade name, or trademark that differs from that 18of the brand name drug.19    "Health benefit plan" means a policy, contract, 20certificate, or agreement entered into, offered, or issued by 21an insurer to provide, deliver, arrange for, pay for, or 22reimburse any of the costs of physical, mental, or behavioral 23health care services. Notwithstanding Sections 122-1 through 24122-4 of this Code, "health benefit plan" includes self-funded 25employee welfare benefit plans.26    "Maximum allowable cost" means the maximum amount that a   10400HB3705ham001- 7 -LRB104 11354 BAB 23828 a1pharmacy benefit manager will reimburse a pharmacy for the 2cost of a drug. 3    "Maximum allowable cost list" means a list of drugs for 4which a maximum allowable cost has been established by a 5pharmacy benefit manager. 6    "Pharmacy benefit manager" means a person, business, or 7entity, including a wholly or partially owned or controlled 8subsidiary of a pharmacy benefit manager, that provides claims 9processing services or other prescription drug or device 10services, or both, for health benefit plans.11    "Pharmacy services" means the provision of any services 12listed within the definition of "practice of pharmacy" under 13subsection (d) of Section 3 of the Pharmacy Practice Act.14    "Rare medical condition" means a physical, behavioral, or 15developmental condition that affects fewer than 200,000 16individuals in the United States or approximately 1 in 1,500 17individuals worldwide.18    "Rebate aggregator" means a person or entity, including 19group purchasing organizations, that negotiate rebates or 20other fees with drug manufacturers on behalf or for the 21benefit of a pharmacy benefit manager or its client and may 22also be involved in contracts that entitle the rebate 23aggregator or its client to receive rebates or other fees from 24drug manufacturers based on drug utilization or 25administration. 26    "Retail price" means the price an individual without   10400HB3705ham001- 8 -LRB104 11354 BAB 23828 a1prescription drug coverage would pay at a retail pharmacy, not 2including a pharmacist dispensing fee. 3    "Specialty drug" means a drug that:4        (1) is prescribed for a person with a complex or 5    chronic medical condition or a rare medical condition;6        (2) has limited or exclusive distribution; and7        (3) requires both:8            (A) specialized product handling by the dispensing 9        pharmacy or administration by the dispensing pharmacy; 10        and11            (B) specialized clinical care, including frequent 12        dosing adjustments, intensive clinical monitoring, or 13        expanded services for patients, including intensive 14        patient counseling, education, or ongoing clinical 15        support beyond traditional dispensing activities, such 16        as individualized disease and therapy management to 17        support improved health outcomes.18    "Spread pricing" means the model of drug pricing in which 19the pharmacy benefit manager charges a health benefit plan a 20contracted price for drugs, and the contracted price for the 21drugs differs from the amount the pharmacy benefit manager 22directly or indirectly pays the pharmacist or pharmacy for 23pharmacist services or drug and dispensing fees.24    "Steer" includes, but is not limited to:25        (1) requiring a covered individual to use only a 26    pharmacy, including a mail-order or specialty pharmacy, in   10400HB3705ham001- 9 -LRB104 11354 BAB 23828 a1    which the pharmacy benefit manager or its affiliate 2    maintains an ownership interest or control;3        (2) offering or implementing a plan design that 4    encourages a covered individual to use a pharmacy in which 5    the pharmacy benefit manager or an affiliate maintains an 6    ownership interest or control, if such plan design 7    increases costs for the covered individual. This includes 8    a plan design that requires a covered individual to pay 9    higher costs or an increased share of costs for a drug or 10    drug-related service if the covered individual uses a 11    pharmacy that is not owned or controlled by the pharmacy 12    benefit manager.13        (3) reimbursing a pharmacy or pharmacist for a 14    pharmaceutical product and pharmacist service in an amount 15    less than the amount that the pharmacy benefit manager 16    reimburses itself or an affiliate, including affiliated 17    manufacturers or joint ventures for providing the same 18    product or services. 19    "Third-party payer" means any entity that pays for 20prescription drugs on behalf of a patient other than a health 21care provider or sponsor of a plan subject to regulation under 22Medicare Part D, 42 U.S.C. 1395w-101 et seq.23    (a-5) In this Article, references to an "insurer" or 24"health insurer" shall include commercial private health 25insurance issuers, managed care organizations, managed care 26community networks, and any other third-party payer that   10400HB3705ham001- 10 -LRB104 11354 BAB 23828 a1contracts with pharmacy benefit managers or with the 2Department of Healthcare and Family Services to provide 3benefits or services under the Medicaid program or to 4otherwise engage in the administration or payment of pharmacy 5benefits. However, the terms do not refer to the plan sponsor 6of a self-funded, single-employer employee welfare benefit 7plan subject to 29 U.S.C. 1144.8    (b) A contract between a health insurer and a pharmacy 9benefit manager must require that the pharmacy benefit 10manager: 11        (1) Update maximum allowable cost pricing information 12    at least every 7 calendar days. 13        (2) Maintain a process that will, in a timely manner, 14    eliminate drugs from maximum allowable cost lists or 15    modify drug prices to remain consistent with changes in 16    pricing data used in formulating maximum allowable cost 17    prices and product availability. 18        (3) Provide access to its maximum allowable cost list 19    to each pharmacy or pharmacy services administrative 20    organization subject to the maximum allowable cost list. 21    Access may include a real-time pharmacy website portal to 22    be able to view the maximum allowable cost list. As used in 23    this Section, "pharmacy services administrative 24    organization" means an entity operating within the State 25    that contracts with independent pharmacies to conduct 26    business on their behalf with third-party payers. A   10400HB3705ham001- 11 -LRB104 11354 BAB 23828 a1    pharmacy services administrative organization may provide 2    administrative services to pharmacies and negotiate and 3    enter into contracts with third-party payers or pharmacy 4    benefit managers on behalf of pharmacies. 5        (4) Provide a process by which a contracted pharmacy 6    can appeal the provider's reimbursement for a drug subject 7    to maximum allowable cost pricing. The appeals process 8    must, at a minimum, include the following: 9            (A) A requirement that a contracted pharmacy has 10        14 calendar days after the applicable fill date to 11        appeal a maximum allowable cost if the reimbursement 12        for the drug is less than the net amount that the 13        network provider paid to the supplier of the drug. 14            (B) A requirement that a pharmacy benefit manager 15        must respond to a challenge within 14 calendar days of 16        the contracted pharmacy making the claim for which the 17        appeal has been submitted.18            (C) A telephone number and e-mail address or 19        website to network providers, at which the provider 20        can contact the pharmacy benefit manager to process 21        and submit an appeal.22            (D) A requirement that, if an appeal is denied, 23        the pharmacy benefit manager must provide the reason 24        for the denial and the name and the national drug code 25        number from national or regional wholesalers.26            (E) A requirement that, if an appeal is sustained,   10400HB3705ham001- 12 -LRB104 11354 BAB 23828 a1        the pharmacy benefit manager must make an adjustment 2        in the drug price effective the date the challenge is 3        resolved and make the adjustment applicable to all 4        similarly situated network pharmacy providers, as 5        determined by the managed care organization or 6        pharmacy benefit manager. 7        (5) Allow a plan sponsor or insurer whose coverage is 8    administered by the contracting with a pharmacy benefit 9    manager an annual right to audit compliance with the terms 10    of the contract by the pharmacy benefit manager, 11    including, but not limited to, full disclosure of any and 12    all rebate amounts secured, whether product specific or 13    generalized rebates, that were provided to the pharmacy 14    benefit manager by a pharmaceutical manufacturer. The cost 15    of the audit shall be borne exclusively by the pharmacy 16    benefit manager. 17        (6) Allow a plan sponsor or insurer whose coverage is 18    administered by the contracting with a pharmacy benefit 19    manager to request that the pharmacy benefit manager 20    disclose the actual amounts paid by the pharmacy benefit 21    manager to the pharmacy.22        (7) Provide notice to the plan sponsor or the insurer 23    party contracting with the pharmacy benefit manager of any 24    consideration that the pharmacy benefit manager receives 25    from the manufacturer for dispense as written 26    prescriptions once a generic or biologically similar   10400HB3705ham001- 13 -LRB104 11354 BAB 23828 a1    product becomes available. 2    (c) In order to place a particular prescription drug on a 3maximum allowable cost list, the pharmacy benefit manager 4must, at a minimum, ensure that: 5        (1) if the drug is a generically equivalent drug, it 6    is listed as therapeutically equivalent and 7    pharmaceutically equivalent "A" or "B" rated in the United 8    States Food and Drug Administration's most recent version 9    of the "Orange Book" or have an NR or NA rating by 10    Medi-Span, Gold Standard, or a similar rating by a 11    nationally recognized reference; 12        (2) the drug is available for purchase by each 13    pharmacy in the State from national or regional 14    wholesalers operating in Illinois; and 15        (3) the drug is not obsolete. 16    (d) A pharmacy benefit manager is prohibited from limiting 17a pharmacist's ability to disclose whether the cost-sharing 18obligation exceeds the retail price for a covered prescription 19drug, and the availability of a more affordable alternative 20drug, if one is available in accordance with Section 42 of the 21Pharmacy Practice Act. 22    (e) A health insurer or pharmacy benefit manager shall not 23require a covered individual an insured to make a payment for a 24prescription drug at the point of sale in an amount that 25exceeds the lesser of: 26        (1) the applicable cost-sharing amount; or  10400HB3705ham001- 14 -LRB104 11354 BAB 23828 a1        (2) the retail price of the drug in the absence of 2    prescription drug coverage;3        (3) the discounted price available through a no cost 4    drug program or drug manufacturer voucher provided by or 5    for the covered individual at the point of sale; or6        (4) the discounted price available through a 7    discounted health care services plan provided by or for 8    the covered individual at the point of sale. 9    (f) Unless required by law, a contract between a pharmacy 10benefit manager or third-party payer and a 340B entity or 340B 11pharmacy shall not contain any provision that: 12        (1) distinguishes between drugs purchased through the 13    340B drug discount program and other drugs when 14    determining reimbursement or reimbursement methodologies, 15    or contains otherwise less favorable payment terms or 16    reimbursement methodologies for 340B entities or 340B 17    pharmacies when compared to similarly situated non-340B 18    entities; 19        (2) imposes any fee, chargeback, or rate adjustment 20    that is not similarly imposed on similarly situated 21    pharmacies that are not 340B entities or 340B pharmacies; 22        (3) imposes any fee, chargeback, or rate adjustment 23    that exceeds the fee, chargeback, or rate adjustment that 24    is not similarly imposed on similarly situated pharmacies 25    that are not 340B entities or 340B pharmacies; 26        (4) prevents or interferes with an individual's choice   10400HB3705ham001- 15 -LRB104 11354 BAB 23828 a1    to receive a covered prescription drug from a 340B entity 2    or 340B pharmacy through any legally permissible means, 3    except that nothing in this paragraph shall prohibit the 4    establishment of differing copayments or other 5    cost-sharing amounts within the health benefit plan for 6    covered individuals persons who acquire covered 7    prescription drugs from a nonpreferred or nonparticipating 8    provider; 9        (5) excludes a 340B entity or 340B pharmacy from a 10    pharmacy network on any basis that includes consideration 11    of whether the 340B entity or 340B pharmacy participates 12    in the 340B drug discount program; 13        (6) prevents a 340B entity or 340B pharmacy from using 14    a drug purchased under the 340B drug discount program; or 15        (7) any other provision that discriminates against a 16    340B entity or 340B pharmacy by treating the 340B entity 17    or 340B pharmacy differently than non-340B entities or 18    non-340B pharmacies for any reason relating to the 19    entity's participation in the 340B drug discount program. 20    As used in this subsection, "pharmacy benefit manager" and 21"third-party payer" do not include pharmacy benefit managers 22and third-party payers acting on behalf of a Medicaid program.23    (f-5) A pharmacy benefit manager or an affiliate acting on 24its behalf must reimburse pharmacies no less than 90% of the 25amount the pharmacy benefit manager, or its affiliate, charges 26the insurer or plan sponsor for the drug, item, or service.   10400HB3705ham001- 16 -LRB104 11354 BAB 23828 a1Spread pricing percentages by drug, insurer or plan sponsor, 2and pharmacy must be disclosed to the Department in an annual 3spread pricing filing. Any amount not paid to the pharmacies 4must be excluded from the 90% threshold.5    (f-10) A pharmacy benefit manager or an affiliate acting 6on its behalf shall not steer a covered individual.7    (f-15) A pharmacy benefit manager or rebate aggregator 8must remit no less than 90% of any amounts paid by a 9pharmaceutical manufacturer, wholesaler, or other distributor 10of a drug, including, but not limited to, rebates, group 11purchasing fees, and other fees, to the health benefit plan 12sponsor, covered individual, or employer. Records of rebates 13and fees remitted from the pharmacy benefit manager or rebate 14aggregator must be disclosed to the Department annually in a 15format to be specified by the Department.16    (f-20) A pharmacy benefit manager must not reimburse a 17critical access pharmacy for a drug or pharmacy service in an 18amount less than the national average drug acquisition cost 19for the drug or pharmacy service at the time the drug is 20administered or dispensed, plus the current Medicaid critical 21access pharmacy dispensing fee. If the national average drug 22acquisition cost is not available at the time a drug is 23administered or dispensed, a pharmacy benefit manager must not 24reimburse a critical access pharmacy for any drug at a rate 25that is less than the amount established by the Department of 26Healthcare and Family Services for the drug or service under   10400HB3705ham001- 17 -LRB104 11354 BAB 23828 a1the Medicaid program, as set forth in the applicable 2administrative rule, plus the current Medicaid critical access 3pharmacy dispensing fee.4    (f-25) A pharmacy benefit manager or an affiliate acting 5on its behalf is prohibited from limiting a covered 6individual's access to drugs from a pharmacy or pharmacist 7enrolled with the health benefit plan under the terms offered 8to all pharmacies in the plan coverage area, including by 9designating the covered drug as a specialty drug contrary to 10the definition in this Section.11    (f-30) The contract between the pharmacy benefit manager 12and the insurer or health benefit plan sponsor must allow and 13provide for the pharmacy benefit manager's compliance with an 14audit at least once per calendar year of the rebate and fee 15records remitted from a pharmacy benefit manager or its 16affiliated party to a health benefit plan. This audit may be 17incorporated into the audit under paragraph (5) of subsection 18(b) of this Section. Contracts with rebate aggregators, 19pharmacy services administrative organizations, pharmacies, or 20drug manufacturers must be available for audit by health 21benefit plan sponsors, insurers, or their designees at least 22once per plan year. Audits shall be performed by an auditor 23selected by the health benefit plan sponsor, insurer, or its 24designee. Health benefit plan sponsors and insurers shall give 25the pharmacy benefit manager a complete copy of the audit and 26the pharmacy benefit manager shall provide a complete copy of   10400HB3705ham001- 18 -LRB104 11354 BAB 23828 a1those findings to the Department within 60 days of initial 2receipt. Rebate contracts with rebate aggregators, pharmacy 3services administrative organizations, pharmacies, or drug 4manufacturers shall be available for audit by health benefit 5plan sponsor, insurer, or designee. Nothing in this Section 6shall limit the Department's ability to access the books and 7records and any and all copies thereof of pharmacy benefit 8managers, their affiliates, or affiliated rebate aggregators. 9    (g) A violation of this Section by a pharmacy benefit 10manager constitutes an unfair or deceptive act or practice in 11the business of insurance under Section 424. 12    (h) A provision that violates subsection (f) in a contract 13between a pharmacy benefit manager or a third-party payer and 14a 340B entity that is entered into, amended, or renewed after 15July 1, 2022 shall be void and unenforceable. This subsection 16and subsection (f) do not apply to a contract between a 340B 17entity and the plan sponsor of a self-funded, single-employer 18employee welfare benefit plan subject to 29 U.S.C. 1144. 19    (i)(1) A pharmacy benefit manager may not retaliate 20against a pharmacist or pharmacy for disclosing information in 21a court, in an administrative hearing, before a legislative 22commission or committee, or in any other proceeding, if the 23pharmacist or pharmacy has reasonable cause to believe that 24the disclosed information is evidence of a violation of a 25State or federal law, rule, or regulation.26    (2) A pharmacy benefit manager may not retaliate against a   10400HB3705ham001- 19 -LRB104 11354 BAB 23828 a1pharmacist or pharmacy for disclosing information to a 2government or law enforcement agency, if the pharmacist or 3pharmacy has reasonable cause to believe that the disclosed 4information is evidence of a violation of a State or federal 5law, rule, or regulation.6    (3) A pharmacist or pharmacy shall make commercially 7reasonable efforts to limit the disclosure of confidential and 8proprietary information.9    (4) Retaliatory actions against a pharmacy or pharmacist 10include cancellation of, restriction of, or refusal to renew 11or offer a contract to a pharmacy solely because the pharmacy 12or pharmacist has:13        (A) made disclosures of information that the 14    pharmacist or pharmacy has reasonable cause to believe is 15    evidence of a violation of a State or federal law, rule, or 16    regulation;17        (B) filed complaints with the plan or pharmacy benefit 18    manager; or19        (C) filed complaints against the plan or pharmacy 20    benefit manager with the Department.21    (j) This Section applies to contracts entered into or 22renewed on or after July 1, 2022 and, unless provided 23otherwise in this Section or in the Illinois Public Aid Code, 24applies to pharmacy benefit managers that are contracted with 25a Medicaid managed care entity on or after January 1, 2026. 26    (k) This Section applies to any health benefit group or   10400HB3705ham001- 20 -LRB104 11354 BAB 23828 a1individual policy of accident and health insurance or managed 2care plan that provides coverage for prescription drugs and 3that is amended, delivered, issued, or renewed on or after 4January 1, 2026 July 1, 2020. 5    (l) A pharmacy benefit manager is responsible for 6compliance with all State requirements applicable to pharmacy 7benefit managers even if an action or responsibility of a 8pharmacy benefit manager is delegated to or completed by a 9third party with an affiliation or a direct or indirect 10contractual relationship. The changes made to this Section by 11this amendatory Act of the 104th General Assembly shall apply 12with respect to any health benefit plan that provides coverage 13for drugs that is amended, delivered, issued, or renewed on or 14after January 1, 2026. 15(Source: P.A. 102-778, eff. 7-1-22; 103-154, eff. 6-30-23; 16103-453, eff. 8-4-23.) 17    (215 ILCS 5/513b1.1 new)18    Sec. 513b1.1. Pharmacy benefit manager reporting 19requirements.20    (a) A pharmacy benefit manager that provides services for 21a health benefit plan must submit an annual report no later 22than September 1, to the Department, each health benefit plan 23sponsor, and each insurer that includes the following:24        (1) data on the health benefit plan including:25            (A) a list of drugs including corresponding   10400HB3705ham001- 21 -LRB104 11354 BAB 23828 a1        information on therapeutic class, brand name, generic 2        name, or specialty drug name;3            (B) number of covered individuals;4            (C) number of drug-related claims;5            (D) dosage units;6            (E) dispensing channel used;7            (F) wholesale acquisition cost; and8            (G) total out-of-pocket spending by deidentified 9        covered individual;10        (2) amount received by the health benefit plan in 11    rebates, fees, or discounts related to drug utilization or 12    spending;13        (3) total gross spending on drugs by the health 14    benefit plan;15        (4) total net spending, gross spending less 16    administrative portion of the medical loss ratio, spread 17    pricing, on drugs by the health benefit plan;18        (5) the amount paid by the health benefit plan to the 19    pharmacy benefit manager for reimbursement cost of a drug 20    per transaction;21        (6) the amount a pharmacy benefit manager paid for 22    pharmacists' services rendered related to the health 23    benefit plan per transaction, including, but not limited 24    to, any dispensing fee;25        (7) the specific rebate amount received by the 26    pharmacy benefit manager per transaction, the amount of   10400HB3705ham001- 22 -LRB104 11354 BAB 23828 a1    the rebates passed through to the health benefit plan per 2    transaction, and the amount of the rebates passed on to 3    covered individuals at the point of sale that reduced the 4    covered individuals' applicable deductible, copayment, 5    coinsurance, or other cost-sharing amount per transaction;6        (8) any information collected from drug manufacturers 7    pertaining to copayment assistance;8        (9) any compensation paid to brokers, consultants, 9    advisors, or any other individual or firm for referrals, 10    consideration, or retention by the health benefit plan;11        (10) explanation of benefit design parameters 12    encouraging or requiring covered individuals to use 13    affiliated pharmacies, percentage of drugs charged by 14    these pharmacies, and a list of drugs dispensed by 15    affiliated pharmacies with their associated costs; and16        (11) a complete copy of each unredacted contract the 17    pharmacy benefit manager has with the health benefit plan 18    sponsor or insurer.19    (b) Annual reports pursuant to subsection (a):20        (1) must be written in plain language to ensure ease 21    of reading and accessibility.22        (2) must only contain summary health information to 23    ensure plan, coverage, or covered individual information 24    remains private and confidential.25        (3) upon request by a covered individual, must be 26    available in summary format and provide aggregated   10400HB3705ham001- 23 -LRB104 11354 BAB 23828 a1    information to help covered individuals understand their 2    health benefit plan's drug coverage.3        (4) must be filed with the Department no later than 4    September 1 of each year via the Systems for Electronic 5    Rates & Forms Filing (SERFF). The filing shall include the 6    summary version of the report described in paragraph (3) 7    of this subsection, which shall be marked for public 8    access.9    (c) A pharmacy benefit manager may petition the Department 10for a filing submission extension. The Director may grant or 11deny the extension within 5 business days.12    (d) Failure by a pharmacy benefit manager to submit all 13required elements in an annual report to the Department may 14result in a fine levied by the Director not to exceed $10,000 15per day, per offense. Funds derived from fines levied shall be 16deposited into the Insurance Producer Administration Fund. 17Fine information shall be posted on the Department's website.18    (e) A pharmacy benefit manager found in violation of 19subsection (a) or paragraph (4) of subsection (b) may request 20a hearing from the Director within 10 days of receipt of the 21Director's order, or, if the violation is found in a market 22conduct examination, as provided in Section 132 of this Code.23    (f) Except for the summary version, the annual reports 24submitted by pharmacy benefit managers shall be considered 25confidential and privileged for all purposes, including for 26purposes of the Freedom of Information Act, shall not be   10400HB3705ham001- 24 -LRB104 11354 BAB 23828 a1subject to subpoena from any private party, and shall not be 2admissible as evidence in a civil action.3    (g) A copy of an adverse decision against a pharmacy 4benefit manager for failing to submit an annual report to the 5Department must be posted to the Department's website.6    (h) Nothing in this Section shall be construed as 7permitting a pharmacy benefit manager to avoid or otherwise 8fail to comply with the reporting requirements set forth in 9Section 5-36 of the Illinois Public Aid Code. 10    (215 ILCS 5/513b3)11    Sec. 513b3. Examination. 12    (a) The Director, or his or her designee, may examine a 13registered pharmacy benefit manager related to all of its 14lines of business, including government programs, under the 15Director's jurisdiction in accordance with Sections 132-132.7. 16If the Director or the examiners find that the pharmacy 17benefit manager has violated this Article or any other 18insurance-related or health benefits-related laws, rules, or 19regulations under the Director's jurisdiction because of the 20manner in which the pharmacy benefit manager has conducted 21business on behalf of a health insurer or plan sponsor, then, 22unless the health insurer or plan sponsor is included in the 23examination and has been afforded the same opportunity to 24request or participate in a hearing on the examination report, 25the examination report shall not allege a violation by the   10400HB3705ham001- 25 -LRB104 11354 BAB 23828 a1health insurer or plan sponsor and the Director's order based 2on the report shall not impose any requirements, prohibitions, 3or penalties on the health insurer or plan sponsor. Nothing in 4this Section shall prevent the Director from using any 5information obtained during the examination of an 6administrator to examine, investigate, or take other 7appropriate regulatory or legal action with respect to a 8health insurer or plan sponsor.9    (b) The examination requirement for the pharmacy benefit 10manager to provide convenient and free access to all books and 11records under Sections 132 and 132.4 of this Code includes, at 12the Director's discretion, unredacted copies furnished 13electronically to the Director's market conduct surveillance 14personnel or examiners. Access must include information 15related to third-party entities affiliated or contracted with 16the pharmacy benefit manager, including, but not limited, to, 17rebate aggregators and pharmacy services administrative 18organizations. 19(Source: P.A. 103-897, eff. 1-1-25.) 20    Section 20. The Illinois Public Aid Code is amended by 21changing Sections 5-5.12b and 5-36 as follows: 22    (305 ILCS 5/5-5.12b)23    Sec. 5-5.12b. Critical access care pharmacy program.24    (a) As used in this Section:   10400HB3705ham001- 26 -LRB104 11354 BAB 23828 a1    "Critical access care pharmacy" means an Illinois-based 2brick and mortar pharmacy that is located in Illinois that is 3owned by a person or entity with an ownership or control 4interest in a county with fewer than 50,000 residents and that 5owns fewer than 10 pharmacies, and is either located in a 6county with fewer than 50,000 residents or in a county with 750,000 or more residents and in an area within Illinois that is 8designated as a Medically Underserved Area by the Health 9Resources and Services Administration, an agency of the U.S. 10Department of Health and Human Services, or at the discretion 11of the Department of Healthcare and Family Services, as set 12forth in administrative rule. 13    "Critical access care pharmacy program payment" means the 14number of individual prescriptions a critical access care 15pharmacy fills during that quarter multiplied by the lesser of 16the individual payment amount or the dispensing reimbursement 17rate made by the Department under the medical assistance 18program as of April 1, 2018. 19    "Individual payment amount" means the dividend of 1/4 of 20the annual amount appropriated for the critical access care 21pharmacy program by the number of prescriptions filled by all 22critical access care pharmacies reimbursed by Medicaid managed 23care organizations that quarter. 24    (b) Subject to appropriations, the Department shall 25establish a critical access care pharmacy program to ensure 26the sustainability of critical access pharmacies throughout   10400HB3705ham001- 27 -LRB104 11354 BAB 23828 a1the State of Illinois. 2    (c) The critical access care pharmacy program shall not 3exceed $10,000,000 annually and individual payment amounts per 4prescription shall not exceed the dispensing rate that the 5Department would have reimbursed under the Medical Assistance 6Program as of April 1, 2018. 7    (d) Quarterly, the Department shall determine the number 8of prescriptions filled by critical access care pharmacies 9reimbursed by Medicaid managed care organizations utilizing 10encounter data available to the Department. The Department 11shall determine the individual payment amount per prescription 12by dividing 1/4 of the annual amount appropriated for the 13critical access care pharmacy program by the number of 14prescriptions filled by all critical access care pharmacies 15reimbursed by Medicaid managed care organizations that 16quarter. If the individual payment amount per prescription as 17calculated using quarterly prescription amounts exceeds the 18reimbursement rate under the medical assistance program as of 19April 1, 2018, then the individual payment amount per 20prescription shall be the dispensing reimbursement rate under 21the medical assistance program as of April 1, 2018. 22    (e) Quarterly, the Department shall distribute to critical 23access care pharmacies a critical access care pharmacy program 24payment. The first payment shall be calculated utilizing the 25encounter data from the last quarter of State fiscal year 262018.  10400HB3705ham001- 28 -LRB104 11354 BAB 23828 a1    (f) The Department may adopt rules permitting an 2Illinois-based brick and mortar pharmacy that owns fewer than 310 pharmacies to receive critical access care pharmacy program 4payments in the same manner as a critical access care 5pharmacy, regardless of whether the pharmacy is located in a 6county with a population of less than 50,000. 7(Source: P.A. 100-587, eff. 6-4-18.) 8    (305 ILCS 5/5-36)9    Sec. 5-36. Pharmacy benefits. 10    (a)(1) The Department may enter into a contract with a 11third party on a fee-for-service reimbursement model for the 12purpose of administering pharmacy benefits as provided in this 13Section for members not enrolled in a Medicaid managed care 14organization; however, these services shall be approved by the 15Department. The Department shall ensure coordination of care 16between the third-party administrator and managed care 17organizations as a consideration in any contracts established 18in accordance with this Section. Any managed care techniques, 19principles, or administration of benefits utilized in 20accordance with this subsection shall comply with State law. 21    (2) The following shall apply to contracts between 22entities contracting relating to the Department's third-party 23administrators and pharmacies: 24        (A) the Department shall approve any contract between 25    a third-party administrator and a pharmacy;  10400HB3705ham001- 29 -LRB104 11354 BAB 23828 a1        (B) the Department's third-party administrator shall 2    not change the terms of a contract between a third-party 3    administrator and a pharmacy without written approval by 4    the Department; and5        (C) the Department's third-party administrator shall 6    not create, modify, implement, or indirectly establish any 7    fee on a pharmacy, pharmacist, or a recipient of medical 8    assistance without written approval by the Department. 9    (b) The provisions of this Section shall not apply to 10outpatient pharmacy services provided by a health care 11facility registered as a covered entity pursuant to 42 U.S.C. 12256b or any pharmacy owned by or contracted with the covered 13entity. A Medicaid managed care organization shall, either 14directly or through a pharmacy benefit manager, administer and 15reimburse outpatient pharmacy claims submitted by a health 16care facility registered as a covered entity pursuant to 42 17U.S.C. 256b, its owned pharmacies, and contracted pharmacies 18in accordance with the contractual agreements the Medicaid 19managed care organization or its pharmacy benefit manager has 20with such facilities and pharmacies and in accordance with 21subsection (h-5). 22    (b-5) Any pharmacy benefit manager that contracts with a 23Medicaid managed care organization to administer and reimburse 24pharmacy claims as provided in this Section must be registered 25with the Director of Insurance in accordance with Section 26513b2 of the Illinois Insurance Code. A pharmacy benefit   10400HB3705ham001- 30 -LRB104 11354 BAB 23828 a1manager must comply with all provisions of Article XXXIIB of 2the Illinois Insurance Code to the extent that they do not 3prevent the application of any provision of this Article or 4applicable federal law. Nothing in this Section shall be 5construed to limit the authority of the Illinois Department or 6the Inspector General to administer or enforce any provisions 7of this Section or any other Section in the Illinois Public Aid 8Code related to pharmacy benefit managers or Medicaid managed 9care entity. 10    (c) On at least an annual basis, the Director of the 11Department of Healthcare and Family Services shall submit a 12report beginning no later than one year after January 1, 2020 13(the effective date of Public Act 101-452) that provides an 14update on any contract, contract issues, formulary, dispensing 15fees, and maximum allowable cost concerns regarding a 16third-party administrator and managed care. The requirement 17for reporting to the General Assembly shall be satisfied by 18filing copies of the report with the Speaker, the Minority 19Leader, and the Clerk of the House of Representatives and with 20the President, the Minority Leader, and the Secretary of the 21Senate. The Department shall take care that no proprietary 22information is included in the report required under this 23Section. 24    (d) (Blank). A pharmacy benefit manager shall notify the 25Department in writing of any activity, policy, or practice of 26the pharmacy benefit manager that directly or indirectly   10400HB3705ham001- 31 -LRB104 11354 BAB 23828 a1presents a conflict of interest that interferes with the 2discharge of the pharmacy benefit manager's duty to a managed 3care organization to exercise its contractual duties. 4"Conflict of interest" shall be defined by rule by the 5Department.6    (e) A pharmacy benefit manager shall, upon request, 7disclose to the Department the following information: 8        (1) whether the pharmacy benefit manager has a 9    contract, agreement, or other arrangement with a 10    pharmaceutical manufacturer to exclusively dispense or 11    provide a drug to a managed care organization's enrollees, 12    and the aggregate amounts of consideration of economic 13    benefits collected or received pursuant to that 14    arrangement; 15        (2) the percentage of claims payments made by the 16    pharmacy benefit manager to pharmacies owned, managed, or 17    controlled by the pharmacy benefit manager or any of the 18    pharmacy benefit manager's management companies, parent 19    companies, subsidiary companies, or jointly held 20    companies; 21        (3) the aggregate amount of the fees or assessments 22    imposed on, or collected from, pharmacy providers; 23        (4) the average annualized percentage of revenue 24    collected by the pharmacy benefit manager as a result of 25    each contract it has executed with a managed care 26    organization contracted by the Department to provide   10400HB3705ham001- 32 -LRB104 11354 BAB 23828 a1    medical assistance benefits which is not paid by the 2    pharmacy benefit manager to pharmacy providers and 3    pharmaceutical manufacturers or labelers or in order to 4    perform administrative functions pursuant to its contracts 5    with managed care organizations; 6        (5) the total number of prescriptions dispensed under 7    each contract the pharmacy benefit manager has with a 8    managed care organization (MCO) contracted by the 9    Department to provide medical assistance benefits;10        (6) the aggregate wholesale acquisition cost for drugs 11    that were dispensed to enrollees in each MCO with which 12    the pharmacy benefit manager has a contract by any 13    pharmacy owned, managed, or controlled by the pharmacy 14    benefit manager or any of the pharmacy benefit manager's 15    management companies, parent companies, subsidiary 16    companies, or jointly-held companies; 17        (7) the aggregate amount of administrative fees that 18    the pharmacy benefit manager received from all 19    pharmaceutical manufacturers for prescriptions dispensed 20    to MCO enrollees; 21        (8) for each MCO with which the pharmacy benefit 22    manager has a contract, the aggregate amount of payments 23    received by the pharmacy benefit manager from the MCO; 24        (9) for each MCO with which the pharmacy benefit 25    manager has a contract, the aggregate amount of 26    reimbursements the pharmacy benefit manager paid to   10400HB3705ham001- 33 -LRB104 11354 BAB 23828 a1    contracting pharmacies; and 2        (10) any other information considered necessary by the 3    Department. 4    (f) The information disclosed under subsection (e) shall 5include all retail, mail order, specialty, and compounded 6prescription products. All information made available to the 7Department under subsection (e) is confidential and not 8subject to disclosure under the Freedom of Information Act. 9All information made available to the Department under 10subsection (e) shall not be reported or distributed in any way 11that compromises its competitive, proprietary, or financial 12value. The information shall only be used by the Department to 13assess the contract, agreement, or other arrangements made 14between a pharmacy benefit manager and a pharmacy provider, 15pharmaceutical manufacturer or labeler, managed care 16organization, or other entity, as applicable. 17    (g) A pharmacy benefit manager shall disclose directly in 18writing to a pharmacy provider or pharmacy services 19administrative organization contracting with the pharmacy 20benefit manager of any material change to a contract provision 21that affects the terms of the reimbursement, the process for 22verifying benefits and eligibility, dispute resolution, 23procedures for verifying drugs included on the formulary, and 24contract termination at least 30 days prior to the date of the 25change to the provision. The terms of this subsection shall be 26deemed met if the pharmacy benefit manager posts the   10400HB3705ham001- 34 -LRB104 11354 BAB 23828 a1information on a website, viewable by the public. A pharmacy 2service administration organization shall notify all contract 3pharmacies of any material change, as described in this 4subsection, within 2 days of notification. As used in this 5Section, "pharmacy services administrative organization" means 6an entity operating within the State that contracts with 7independent pharmacies to conduct business on their behalf 8with third-party payers. A pharmacy services administrative 9organization may provide administrative services to pharmacies 10and negotiate and enter into contracts with third-party payers 11or pharmacy benefit managers on behalf of pharmacies. 12    (h) A pharmacy benefit manager shall not include the 13following in a contract with a pharmacy provider: 14        (1) a provision prohibiting the provider from 15    informing a patient of a less costly alternative to a 16    prescribed medication; or 17        (2) a provision that prohibits the provider from 18    dispensing a particular amount of a prescribed medication, 19    if the pharmacy benefit manager allows that amount to be 20    dispensed through a pharmacy owned or controlled by the 21    pharmacy benefit manager, unless the prescription drug is 22    subject to restricted distribution by the United States 23    Food and Drug Administration or requires special handling, 24    provider coordination, or patient education that cannot be 25    provided by a retail pharmacy. 26    (h-5) Unless required by law, a Medicaid managed care   10400HB3705ham001- 35 -LRB104 11354 BAB 23828 a1organization or pharmacy benefit manager administering or 2managing benefits on behalf of a Medicaid managed care 3organization shall not refuse to contract with a 340B entity 4or 340B pharmacy for refusing to accept less favorable payment 5terms or reimbursement methodologies when compared to 6similarly situated non-340B entities and shall not include in 7a contract with a 340B entity or 340B pharmacy a provision 8that: 9        (1) imposes any fee, chargeback, or rate adjustment 10    that is not similarly imposed on similarly situated 11    pharmacies that are not 340B entities or 340B pharmacies; 12        (2) imposes any fee, chargeback, or rate adjustment 13    that exceeds the fee, chargeback, or rate adjustment that 14    is not similarly imposed on similarly situated pharmacies 15    that are not 340B entities or 340B pharmacies; 16        (3) prevents or interferes with an individual's choice 17    to receive a prescription drug from a 340B entity or 340B 18    pharmacy through any legally permissible means; 19        (4) excludes a 340B entity or 340B pharmacy from a 20    pharmacy network on the basis of whether the 340B entity 21    or 340B pharmacy participates in the 340B drug discount 22    program; 23        (5) prevents a 340B entity or 340B pharmacy from using 24    a drug purchased under the 340B drug discount program so 25    long as the drug recipient is a patient of the 340B entity; 26    nothing in this Section exempts a 340B pharmacy from   10400HB3705ham001- 36 -LRB104 11354 BAB 23828 a1    following the Department's preferred drug list or from any 2    prior approval requirements of the Department or the 3    Medicaid managed care organization that are imposed on the 4    drug for all pharmacies; or 5        (6) any other provision that discriminates against a 6    340B entity or 340B pharmacy by treating a 340B entity or 7    340B pharmacy differently than non-340B entities or 8    non-340B pharmacies for any reason relating to the 9    entity's participation in the 340B drug discount program. 10    A provision that violates this subsection in any contract 11between a Medicaid managed care organization or its pharmacy 12benefit manager and a 340B entity entered into, amended, or 13renewed after July 1, 2022 shall be void and unenforceable. 14    In this subsection (h-5):15    "340B entity" means a covered entity as defined in 42 16U.S.C. 256b(a)(4) authorized to participate in the 340B drug 17discount program.18    "340B pharmacy" means any pharmacy used to dispense 340B 19drugs for a covered entity, whether entity-owned or external. 20    (i) Nothing in this Section shall be construed to prohibit 21a pharmacy benefit manager from requiring the same 22reimbursement and terms and conditions for a pharmacy provider 23as for a pharmacy owned, controlled, or otherwise associated 24with the pharmacy benefit manager. 25    (j) A pharmacy benefit manager shall establish and 26implement a process for the resolution of disputes arising out   10400HB3705ham001- 37 -LRB104 11354 BAB 23828 a1of this Section, which shall be approved by the Department. 2    (k) The Department shall adopt rules establishing 3reasonable dispensing fees for fee-for-service payments in 4accordance with guidance or guidelines from the federal 5Centers for Medicare and Medicaid Services.6(Source: P.A. 102-558, eff. 8-20-21; 102-778, eff. 7-1-22; 7103-593, eff. 6-7-24.) 8    Section 25. The Juvenile Court Act of 1987 is amended by 9changing Section 5-515 as follows: 10    (705 ILCS 405/5-515)11    Sec. 5-515. Medical, and dental, and pharmaceutical 12treatment and care. 13    (a) At all times during temporary custody, detention or 14shelter care, the court may authorize a physician, a hospital 15or any other appropriate health care provider to provide 16medical, dental or surgical procedures or pharmaceuticals if 17those procedures or pharmaceuticals are necessary to safeguard 18the minor's life or health. If the minor is covered under an 19existing medical or dental plan, the county shall be 20reimbursed for the expenses incurred for such services as if 21the minor were not held in temporary custody, detention, or 22shelter care.23    (b) If a provider of temporary custody, detention, or 24shelter care has a contract with a pharmacy benefit manager or   10400HB3705ham001- 38 -LRB104 11354 BAB 23828 a1a contract with an insurance company, health maintenance 2organization, limited health service organization, 3administrative services organization, or any other managed 4care organization or health insurance issuer where a pharmacy 5benefit manager administers the provider's coverage of, 6payment for, or formulary design for drugs necessary to 7safeguard the minor's life or health, the contract with the 8pharmacy benefit manager and the pharmacy benefit manager's 9activities shall be subject to Article XXXIIB of the Illinois 10Insurance Code and the authority of the Director of Insurance 11to enforce such provisions. The provider shall have all the 12rights of a plan sponsor under those provisions. 13(Source: P.A. 90-590, eff. 1-1-99.) 14    Section 30. The Unified Code of Corrections is amended by 15changing Section 3-2-2 as follows: 16    (730 ILCS 5/3-2-2)  (from Ch. 38, par. 1003-2-2)17    Sec. 3-2-2. Powers and duties of the Department. 18    (1) In addition to the powers, duties, and 19responsibilities which are otherwise provided by law, the 20Department shall have the following powers:21        (a) To accept persons committed to it by the courts of 22    this State for care, custody, treatment, and 23    rehabilitation, and to accept federal prisoners and 24    noncitizens over whom the Office of the Federal Detention   10400HB3705ham001- 39 -LRB104 11354 BAB 23828 a1    Trustee is authorized to exercise the federal detention 2    function for limited purposes and periods of time.3        (b) To develop and maintain reception and evaluation 4    units for purposes of analyzing the custody and 5    rehabilitation needs of persons committed to it and to 6    assign such persons to institutions and programs under its 7    control or transfer them to other appropriate agencies. In 8    consultation with the Department of Alcoholism and 9    Substance Abuse (now the Department of Human Services), 10    the Department of Corrections shall develop a master plan 11    for the screening and evaluation of persons committed to 12    its custody who have alcohol or drug abuse problems, and 13    for making appropriate treatment available to such 14    persons; the Department shall report to the General 15    Assembly on such plan not later than April 1, 1987. The 16    maintenance and implementation of such plan shall be 17    contingent upon the availability of funds.18        (b-1) To create and implement, on January 1, 2002, a 19    pilot program to establish the effectiveness of 20    pupillometer technology (the measurement of the pupil's 21    reaction to light) as an alternative to a urine test for 22    purposes of screening and evaluating persons committed to 23    its custody who have alcohol or drug problems. The pilot 24    program shall require the pupillometer technology to be 25    used in at least one Department of Corrections facility. 26    The Director may expand the pilot program to include an   10400HB3705ham001- 40 -LRB104 11354 BAB 23828 a1    additional facility or facilities as he or she deems 2    appropriate. A minimum of 4,000 tests shall be included in 3    the pilot program. The Department must report to the 4    General Assembly on the effectiveness of the program by 5    January 1, 2003.6        (b-5) To develop, in consultation with the Illinois 7    State Police, a program for tracking and evaluating each 8    inmate from commitment through release for recording his 9    or her gang affiliations, activities, or ranks.10        (c) To maintain and administer all State correctional 11    institutions and facilities under its control and to 12    establish new ones as needed. Pursuant to its power to 13    establish new institutions and facilities, the Department 14    may, with the written approval of the Governor, authorize 15    the Department of Central Management Services to enter 16    into an agreement of the type described in subsection (d) 17    of Section 405-300 of the Department of Central Management 18    Services Law. The Department shall designate those 19    institutions which shall constitute the State Penitentiary 20    System. The Department of Juvenile Justice shall maintain 21    and administer all State youth centers pursuant to 22    subsection (d) of Section 3-2.5-20. 23        Pursuant to its power to establish new institutions 24    and facilities, the Department may authorize the 25    Department of Central Management Services to accept bids 26    from counties and municipalities for the construction,   10400HB3705ham001- 41 -LRB104 11354 BAB 23828 a1    remodeling, or conversion of a structure to be leased to 2    the Department of Corrections for the purposes of its 3    serving as a correctional institution or facility. Such 4    construction, remodeling, or conversion may be financed 5    with revenue bonds issued pursuant to the Industrial 6    Building Revenue Bond Act by the municipality or county. 7    The lease specified in a bid shall be for a term of not 8    less than the time needed to retire any revenue bonds used 9    to finance the project, but not to exceed 40 years. The 10    lease may grant to the State the option to purchase the 11    structure outright.12        Upon receipt of the bids, the Department may certify 13    one or more of the bids and shall submit any such bids to 14    the General Assembly for approval. Upon approval of a bid 15    by a constitutional majority of both houses of the General 16    Assembly, pursuant to joint resolution, the Department of 17    Central Management Services may enter into an agreement 18    with the county or municipality pursuant to such bid.19        (c-5) To build and maintain regional juvenile 20    detention centers and to charge a per diem to the counties 21    as established by the Department to defray the costs of 22    housing each minor in a center. In this subsection (c-5), 23    "juvenile detention center" means a facility to house 24    minors during pendency of trial who have been transferred 25    from proceedings under the Juvenile Court Act of 1987 to 26    prosecutions under the criminal laws of this State in   10400HB3705ham001- 42 -LRB104 11354 BAB 23828 a1    accordance with Section 5-805 of the Juvenile Court Act of 2    1987, whether the transfer was by operation of law or 3    permissive under that Section. The Department shall 4    designate the counties to be served by each regional 5    juvenile detention center.6        (d) To develop and maintain programs of control, 7    rehabilitation, and employment of committed persons within 8    its institutions.9        (d-5) To provide a pre-release job preparation program 10    for inmates at Illinois adult correctional centers. 11        (d-10) To provide educational and visitation 12    opportunities to committed persons within its institutions 13    through temporary access to content-controlled tablets 14    that may be provided as a privilege to committed persons 15    to induce or reward compliance. 16        (e) To establish a system of supervision and guidance 17    of committed persons in the community.18        (f) To establish in cooperation with the Department of 19    Transportation to supply a sufficient number of prisoners 20    for use by the Department of Transportation to clean up 21    the trash and garbage along State, county, township, or 22    municipal highways as designated by the Department of 23    Transportation. The Department of Corrections, at the 24    request of the Department of Transportation, shall furnish 25    such prisoners at least annually for a period to be agreed 26    upon between the Director of Corrections and the Secretary   10400HB3705ham001- 43 -LRB104 11354 BAB 23828 a1    of Transportation. The prisoners used on this program 2    shall be selected by the Director of Corrections on 3    whatever basis he deems proper in consideration of their 4    term, behavior and earned eligibility to participate in 5    such program - where they will be outside of the prison 6    facility but still in the custody of the Department of 7    Corrections. Prisoners convicted of first degree murder, 8    or a Class X felony, or armed violence, or aggravated 9    kidnapping, or criminal sexual assault, aggravated 10    criminal sexual abuse or a subsequent conviction for 11    criminal sexual abuse, or forcible detention, or arson, or 12    a prisoner adjudged a Habitual Criminal shall not be 13    eligible for selection to participate in such program. The 14    prisoners shall remain as prisoners in the custody of the 15    Department of Corrections and such Department shall 16    furnish whatever security is necessary. The Department of 17    Transportation shall furnish trucks and equipment for the 18    highway cleanup program and personnel to supervise and 19    direct the program. Neither the Department of Corrections 20    nor the Department of Transportation shall replace any 21    regular employee with a prisoner.22        (g) To maintain records of persons committed to it and 23    to establish programs of research, statistics, and 24    planning.25        (h) To investigate the grievances of any person 26    committed to the Department and to inquire into any   10400HB3705ham001- 44 -LRB104 11354 BAB 23828 a1    alleged misconduct by employees or committed persons; and 2    for these purposes it may issue subpoenas and compel the 3    attendance of witnesses and the production of writings and 4    papers, and may examine under oath any witnesses who may 5    appear before it; to also investigate alleged violations 6    of a parolee's or releasee's conditions of parole or 7    release; and for this purpose it may issue subpoenas and 8    compel the attendance of witnesses and the production of 9    documents only if there is reason to believe that such 10    procedures would provide evidence that such violations 11    have occurred.12        If any person fails to obey a subpoena issued under 13    this subsection, the Director may apply to any circuit 14    court to secure compliance with the subpoena. The failure 15    to comply with the order of the court issued in response 16    thereto shall be punishable as contempt of court.17        (i) To appoint and remove the chief administrative 18    officers, and administer programs of training and 19    development of personnel of the Department. Personnel 20    assigned by the Department to be responsible for the 21    custody and control of committed persons or to investigate 22    the alleged misconduct of committed persons or employees 23    or alleged violations of a parolee's or releasee's 24    conditions of parole shall be conservators of the peace 25    for those purposes, and shall have the full power of peace 26    officers outside of the facilities of the Department in   10400HB3705ham001- 45 -LRB104 11354 BAB 23828 a1    the protection, arrest, retaking, and reconfining of 2    committed persons or where the exercise of such power is 3    necessary to the investigation of such misconduct or 4    violations. This subsection shall not apply to persons 5    committed to the Department of Juvenile Justice under the 6    Juvenile Court Act of 1987 on aftercare release.7        (j) To cooperate with other departments and agencies 8    and with local communities for the development of 9    standards and programs for better correctional services in 10    this State.11        (k) To administer all moneys and properties of the 12    Department.13        (l) To report annually to the Governor on the 14    committed persons, institutions, and programs of the 15    Department.16        (l-5) (Blank).17        (m) To make all rules and regulations and exercise all 18    powers and duties vested by law in the Department.19        (n) To establish rules and regulations for 20    administering a system of sentence credits, established in 21    accordance with Section 3-6-3, subject to review by the 22    Prisoner Review Board.23        (o) To administer the distribution of funds from the 24    State Treasury to reimburse counties where State penal 25    institutions are located for the payment of assistant 26    state's attorneys' salaries under Section 4-2001 of the   10400HB3705ham001- 46 -LRB104 11354 BAB 23828 a1    Counties Code.2        (p) To exchange information with the Department of 3    Human Services and the Department of Healthcare and Family 4    Services for the purpose of verifying living arrangements 5    and for other purposes directly connected with the 6    administration of this Code and the Illinois Public Aid 7    Code.8        (q) To establish a diversion program.9        The program shall provide a structured environment for 10    selected technical parole or mandatory supervised release 11    violators and committed persons who have violated the 12    rules governing their conduct while in work release. This 13    program shall not apply to those persons who have 14    committed a new offense while serving on parole or 15    mandatory supervised release or while committed to work 16    release.17        Elements of the program shall include, but shall not 18    be limited to, the following:19            (1) The staff of a diversion facility shall 20        provide supervision in accordance with required 21        objectives set by the facility.22            (2) Participants shall be required to maintain 23        employment.24            (3) Each participant shall pay for room and board 25        at the facility on a sliding-scale basis according to 26        the participant's income.  10400HB3705ham001- 47 -LRB104 11354 BAB 23828 a1            (4) Each participant shall:2                (A) provide restitution to victims in 3            accordance with any court order;4                (B) provide financial support to his 5            dependents; and6                (C) make appropriate payments toward any other 7            court-ordered obligations.8            (5) Each participant shall complete community 9        service in addition to employment.10            (6) Participants shall take part in such 11        counseling, educational, and other programs as the 12        Department may deem appropriate.13            (7) Participants shall submit to drug and alcohol 14        screening.15            (8) The Department shall promulgate rules 16        governing the administration of the program.17        (r) To enter into intergovernmental cooperation 18    agreements under which persons in the custody of the 19    Department may participate in a county impact 20    incarceration program established under Section 3-6038 or 21    3-15003.5 of the Counties Code.22        (r-5) (Blank).23        (r-10) To systematically and routinely identify with 24    respect to each streetgang active within the correctional 25    system: (1) each active gang; (2) every existing 26    inter-gang affiliation or alliance; and (3) the current   10400HB3705ham001- 48 -LRB104 11354 BAB 23828 a1    leaders in each gang. The Department shall promptly 2    segregate leaders from inmates who belong to their gangs 3    and allied gangs. "Segregate" means no physical contact 4    and, to the extent possible under the conditions and space 5    available at the correctional facility, prohibition of 6    visual and sound communication. For the purposes of this 7    paragraph (r-10), "leaders" means persons who:8            (i) are members of a criminal streetgang;9            (ii) with respect to other individuals within the 10        streetgang, occupy a position of organizer, 11        supervisor, or other position of management or 12        leadership; and13            (iii) are actively and personally engaged in 14        directing, ordering, authorizing, or requesting 15        commission of criminal acts by others, which are 16        punishable as a felony, in furtherance of streetgang 17        related activity both within and outside of the 18        Department of Corrections.19    "Streetgang", "gang", and "streetgang related" have the 20    meanings ascribed to them in Section 10 of the Illinois 21    Streetgang Terrorism Omnibus Prevention Act.22        (s) To operate a super-maximum security institution, 23    in order to manage and supervise inmates who are 24    disruptive or dangerous and provide for the safety and 25    security of the staff and the other inmates.26        (t) To monitor any unprivileged conversation or any   10400HB3705ham001- 49 -LRB104 11354 BAB 23828 a1    unprivileged communication, whether in person or by mail, 2    telephone, or other means, between an inmate who, before 3    commitment to the Department, was a member of an organized 4    gang and any other person without the need to show cause or 5    satisfy any other requirement of law before beginning the 6    monitoring, except as constitutionally required. The 7    monitoring may be by video, voice, or other method of 8    recording or by any other means. As used in this 9    subdivision (1)(t), "organized gang" has the meaning 10    ascribed to it in Section 10 of the Illinois Streetgang 11    Terrorism Omnibus Prevention Act.12        As used in this subdivision (1)(t), "unprivileged 13    conversation" or "unprivileged communication" means a 14    conversation or communication that is not protected by any 15    privilege recognized by law or by decision, rule, or order 16    of the Illinois Supreme Court.17        (u) To establish a Women's and Children's Pre-release 18    Community Supervision Program for the purpose of providing 19    housing and services to eligible female inmates, as 20    determined by the Department, and their newborn and young 21    children.22        (u-5) To issue an order, whenever a person committed 23    to the Department absconds or absents himself or herself, 24    without authority to do so, from any facility or program 25    to which he or she is assigned. The order shall be 26    certified by the Director, the Supervisor of the   10400HB3705ham001- 50 -LRB104 11354 BAB 23828 a1    Apprehension Unit, or any person duly designated by the 2    Director, with the seal of the Department affixed. The 3    order shall be directed to all sheriffs, coroners, and 4    police officers, or to any particular person named in the 5    order. Any order issued pursuant to this subdivision 6    (1)(u-5) shall be sufficient warrant for the officer or 7    person named in the order to arrest and deliver the 8    committed person to the proper correctional officials and 9    shall be executed the same as criminal process. 10        (u-6) To appoint a point of contact person who shall 11    receive suggestions, complaints, or other requests to the 12    Department from visitors to Department institutions or 13    facilities and from other members of the public.14        (v) To do all other acts necessary to carry out the 15    provisions of this Chapter.16    (2) The Department of Corrections shall by January 1, 171998, consider building and operating a correctional facility 18within 100 miles of a county of over 2,000,000 inhabitants, 19especially a facility designed to house juvenile participants 20in the impact incarceration program.21    (3) When the Department lets bids for contracts for 22medical services to be provided to persons committed to 23Department facilities by a health maintenance organization, 24medical service corporation, or other health care provider, 25the bid may only be let to a health care provider that has 26obtained an irrevocable letter of credit or performance bond   10400HB3705ham001- 51 -LRB104 11354 BAB 23828 a1issued by a company whose bonds have an investment grade or 2higher rating by a bond rating organization.3    (3.5) If the Department has a contract with a pharmacy 4benefit manager or a contract with an insurance company, 5health maintenance organization, limited health service 6organization, administrative services organization, or any 7other managed care entity or health insurance issuer where a 8pharmacy benefit manager administers the provider's coverage 9of, payment for, or formulary design for drugs necessary to 10safeguard the minor's life or health, the contract with the 11pharmacy benefit manager and the pharmacy benefit manager's 12activities shall be subject to Article XXXIIB of the Illinois 13Insurance Code and the authority of the Director of Insurance 14to enforce such provisions. The provider shall have all the 15rights of a plan sponsor under those provisions. 16    (4) When the Department lets bids for contracts for food 17or commissary services to be provided to Department 18facilities, the bid may only be let to a food or commissary 19services provider that has obtained an irrevocable letter of 20credit or performance bond issued by a company whose bonds 21have an investment grade or higher rating by a bond rating 22organization.23    (5) On and after the date 6 months after August 16, 2013 24(the effective date of Public Act 98-488), as provided in the 25Executive Order 1 (2012) Implementation Act, all of the 26powers, duties, rights, and responsibilities related to State   10400HB3705ham001- 52 -LRB104 11354 BAB 23828 a1healthcare purchasing under this Code that were transferred 2from the Department of Corrections to the Department of 3Healthcare and Family Services by Executive Order 3 (2005) are 4transferred back to the Department of Corrections; however, 5powers, duties, rights, and responsibilities related to State 6healthcare purchasing under this Code that were exercised by 7the Department of Corrections before the effective date of 8Executive Order 3 (2005) but that pertain to individuals 9resident in facilities operated by the Department of Juvenile 10Justice are transferred to the Department of Juvenile Justice. 11    (6) The Department of Corrections shall provide lactation 12or nursing mothers rooms for personnel of the Department. The 13rooms shall be provided in each facility of the Department 14that employs nursing mothers. Each individual lactation room 15must: 16        (i) contain doors that lock; 17        (ii) have an "Occupied" sign for each door; 18        (iii) contain electrical outlets for plugging in 19    breast pumps; 20        (iv) have sufficient lighting and ventilation; 21        (v) contain comfortable chairs; 22        (vi) contain a countertop or table for all necessary 23    supplies for lactation; 24        (vii) contain a wastebasket and chemical cleaners to 25    wash one's hands and to clean the surfaces of the 26    countertop or table;   10400HB3705ham001- 53 -LRB104 11354 BAB 23828 a1        (viii) have a functional sink; 2        (ix) have a minimum of one refrigerator for storage of 3    the breast milk; and 4        (x) receive routine daily maintenance. 5(Source: P.A. 102-350, eff. 8-13-21; 102-535, eff. 1-1-22; 6102-538, eff. 8-20-21; 102-813, eff. 5-13-22; 102-1030, eff. 75-27-22; 103-834, eff. 1-1-25.) 8    Section 35. The County Jail Act is amended by changing 9Section 17 as follows: 10    (730 ILCS 125/17)  (from Ch. 75, par. 117)11    Sec. 17. Bedding, clothing, fuel, and medical aid; 12reimbursement for medical expenses. The Warden of the jail 13shall furnish necessary bedding, clothing, fuel, and medical 14services for all committed persons under his charge, and keep 15an accurate account of the same. When services that result in 16qualified medical expenses are required by any person held in 17custody, the county, private hospital, physician or any public 18agency which provides such services shall be entitled to 19obtain reimbursement from the county for the cost of such 20services. The county board of a county may adopt an ordinance 21or resolution providing for reimbursement for the cost of 22those services at the Department of Healthcare and Family 23Services' rates for medical assistance. To the extent that 24such person is reasonably able to pay for such care, including   10400HB3705ham001- 54 -LRB104 11354 BAB 23828 a1reimbursement from any insurance program or from other medical 2benefit programs available to such person, he or she shall 3reimburse the county or arresting authority. If such person 4has already been determined eligible for medical assistance 5under the Illinois Public Aid Code at the time the person is 6detained, the cost of such services, to the extent such cost 7exceeds $500, shall be reimbursed by the Department of 8Healthcare and Family Services under that Code. A 9reimbursement under any public or private program authorized 10by this Section shall be paid to the county or arresting 11authority to the same extent as would have been obtained had 12the services been rendered in a non-custodial environment.13    The sheriff or his or her designee may cause an 14application for medical assistance under the Illinois Public 15Aid Code to be completed for an arrestee who is a hospital 16inpatient. If such arrestee is determined eligible, he or she 17shall receive medical assistance under the Code for hospital 18inpatient services only. An arresting authority shall be 19responsible for any qualified medical expenses relating to the 20arrestee until such time as the arrestee is placed in the 21custody of the sheriff. However, the arresting authority shall 22not be so responsible if the arrest was made pursuant to a 23request by the sheriff. When medical expenses are required by 24any person held in custody, the county shall be entitled to 25obtain reimbursement from the County Jail Medical Costs Fund 26to the extent moneys are available from the Fund. To the extent   10400HB3705ham001- 55 -LRB104 11354 BAB 23828 a1that the person is reasonably able to pay for that care, 2including reimbursement from any insurance program or from 3other medical benefit programs available to the person, he or 4she shall reimburse the county.5    For the purposes of this Section, "arresting authority" 6means a unit of local government, other than a county, which 7employs peace officers and whose peace officers have made the 8arrest of a person. For the purposes of this Section, 9"qualified medical expenses" include medical and hospital 10services but do not include (i) expenses incurred for medical 11care or treatment provided to a person on account of a 12self-inflicted injury incurred prior to or in the course of an 13arrest, (ii) expenses incurred for medical care or treatment 14provided to a person on account of a health condition of that 15person which existed prior to the time of his or her arrest, or 16(iii) expenses for hospital inpatient services for arrestees 17enrolled for medical assistance under the Illinois Public Aid 18Code.19    If a jail or a unit of local government operating the jail 20has a contract with a pharmacy benefit manager or a contract 21with an insurance company, health maintenance organization, 22limited health service organization, administrative services 23organization, or any other managed care organization or health 24insurance issuer where a pharmacy benefit manager administers 25coverage of, payment for, or formulary design for drugs 26necessary to safeguard the life or health of any person in   10400HB3705ham001- 56 -LRB104 11354 BAB 23828 a1custody, that contract and the pharmacy benefit manager's 2activities shall be subject to Article XXXIIB of the Illinois 3Insurance Code and the authority of the Director of Insurance 4to enforce such provisions. The jail or unit of local 5government shall have all the rights of a plan sponsor under 6those provisions. 7(Source: P.A. 103-745, eff. 1-1-25.) 8    Section 99. Effective date. This Act takes effect on 9January 1, 2026, except that this Section and the changes to 10Section 513b3 of the Illinois Insurance Code take effect upon 11becoming law.".